| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.885 | 0.002 | 0.885 | 5 Hydroxytryptamine release stimulant | 0.885 0.002 DBMET00733 0.721 0.006 DBMET00540 0.715 0.006 DBMET02222 0.725 0.005 DBMET01018 0.483 0.03 DBMET01437 0.28 0.076 DBMET00507 | ||
| 0.754 | 0.001 | 0.754 | 5 Hydroxytryptamine uptake stimulant | 0.745 0.001 DBMET00733 0.536 0.004 DBMET00540 0.478 0.005 DBMET02222 0.531 0.004 DBMET01018 0.56 0.003 DBMET01437 0.416 0.012 DBMET00507 | ||
| 0.682 | 0.004 | 0.724 | Psychostimulant | 0.661 0.005 DBMET00733 0.724 0.004 DBMET00540 0.209 0.075 DBMET02222 0.696 0.004 DBMET01018 0.227 0.067 DBMET01437 0.201 0.079 DBMET00507 | DBMET00540 | |
| 0.653 | 0.003 | 0.795 | Tyrosine 3 hydroxylase inhibitor | 0.795 0.002 DBMET00733 0.414 0.007 DBMET00540 0.426 0.006 DBMET02222 0.497 0.004 DBMET01018 0.418 0.006 DBMET01437 0.526 0.004 DBMET00507 | DBMET00733 | |
| 0.614 | 0.009 | 0.704 | 5 Hydroxytryptamine release inhibitor | 0.637 0.007 DBMET00733 0.604 0.01 DBMET00540 0.506 0.03 DBMET02222 0.612 0.009 DBMET01018 0.704 0.004 DBMET01437 0.538 0.022 DBMET00507 | DBMET01437 | |
| 0.597 | 0.004 | 0.597 | 5 Hydroxytryptamine 1F antagonist | 0.376 0.005 DBMET00733 | ||
| 0.593 | 0.004 | 0.593 | 5 Hydroxytryptamine agonist | 0.297 0.008 DBMET00733 0.392 0.005 DBMET00540 0.232 0.012 DBMET01018 | ||
| 0.561 | 0.009 | 0.697 | Superoxide dismutase inhibitor | 0.656 0.005 DBMET00733 0.432 0.021 DBMET00540 0.421 0.023 DBMET02222 0.477 0.015 DBMET01018 0.697 0.004 DBMET01437 0.508 0.012 DBMET00507 | DBMET01437 | |
| 0.522 | 0.03 | 0.846 | Aldehyde oxidase inhibitor | 0.677 0.01 DBMET00733 0.565 0.024 DBMET00540 0.582 0.021 DBMET02222 0.661 0.012 DBMET01018 0.846 0.004 DBMET01437 0.586 0.021 DBMET00507 | DBMET01437 | |
| 0.473 | 0.012 | 0.71 | Peroxidase inhibitor | 0.626 0.004 DBMET00733 0.625 0.004 DBMET00540 0.354 0.028 DBMET02222 0.71 0.003 DBMET01018 0.595 0.005 DBMET01437 0.624 0.004 DBMET00507 | DBMET01018 | |
| 0.431 | 0.012 | 0.431 | Growth hormone agonist | 0.411 0.014 DBMET00733 0.275 0.037 DBMET00540 0.138 0.098 DBMET02222 0.284 0.035 DBMET01018 0.177 0.069 DBMET00507 | ||
| 0.415 | 0.017 | 0.479 | Interleukin agonist | 0.403 0.018 DBMET00733 0.479 0.01 DBMET00540 0.264 0.069 DBMET02222 0.456 0.012 DBMET01018 0.425 0.015 DBMET01437 0.345 0.03 DBMET00507 | DBMET00540 | |
| 0.385 | 0.003 | 0.619 | Phenylalanine 4-hydroxylase inhibitor | 0.553 0.002 DBMET00733 0.537 0.002 DBMET00540 0.158 0.011 DBMET02222 0.619 0.002 DBMET01018 0.431 0.003 DBMET01437 0.253 0.005 DBMET00507 | DBMET01018 | |
| 0.399 | 0.028 | 0.421 | Interleukin 2 agonist | 0.406 0.025 DBMET00733 0.421 0.022 DBMET00540 0.206 0.178 DBMET02222 0.417 0.023 DBMET01018 0.322 0.06 DBMET01437 0.296 0.077 DBMET00507 | DBMET00540 | |
| 0.393 | 0.023 | 0.404 | Insulysin inhibitor | 0.404 0.021 DBMET00733 0.303 0.057 DBMET00540 0.342 0.037 DBMET02222 0.31 0.053 DBMET01018 0.386 0.024 DBMET01437 0.394 0.023 DBMET00507 | DBMET00733 | |
| 0.408 | 0.038 | 0.582 | Spasmolytic | 0.445 0.032 DBMET00733 0.565 0.016 DBMET00540 0.2 0.12 DBMET02222 0.582 0.015 DBMET01018 0.321 0.062 DBMET01437 0.191 0.128 DBMET00507 | DBMET01018 | |
| 0.419 | 0.053 | 0.608 | GABA C receptor rho-3 antagonist | 0.449 0.042 DBMET00733 0.303 0.114 DBMET00540 0.508 0.024 DBMET02222 0.349 0.086 DBMET01018 0.573 0.011 DBMET01437 0.608 0.007 DBMET00507 | DBMET00507 | |
| 0.375 | 0.01 | 0.871 | Alpha-N-acetylglucosaminidase inhibitor | 0.335 0.013 DBMET00733 0.481 0.006 DBMET00540 0.386 0.01 DBMET02222 0.371 0.01 DBMET01018 0.871 0.001 DBMET01437 0.605 0.004 DBMET00507 | DBMET01437 | |
| 0.387 | 0.04 | 0.463 | Vasodilator, coronary | 0.395 0.037 DBMET00733 0.46 0.022 DBMET00540 0.275 0.11 DBMET02222 0.463 0.021 DBMET01018 0.398 0.036 DBMET01437 0.309 0.08 DBMET00507 | DBMET01018 | |
| 0.424 | 0.081 | 0.579 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.299 0.214 DBMET00733 0.37 0.129 DBMET00540 0.457 0.057 DBMET02222 0.267 0.261 DBMET01018 0.579 0.01 DBMET01437 0.489 0.039 DBMET00507 | DBMET01437 | |
| 0.408 | 0.072 | 0.682 | Histamine release inhibitor | 0.46 0.045 DBMET00733 0.548 0.017 DBMET00540 0.377 0.087 DBMET02222 0.579 0.012 DBMET01018 0.682 0.005 DBMET01437 0.523 0.022 DBMET00507 | DBMET01437 | |
| 0.408 | 0.076 | 0.593 | Calcium channel L-type activator | 0.475 0.038 DBMET00733 0.592 0.006 DBMET00540 0.456 0.047 DBMET02222 0.593 0.006 DBMET01018 0.542 0.015 DBMET01437 0.397 0.083 DBMET00507 | DBMET01018 | |
| 0.354 | 0.023 | 0.44 | Anesthetic general | 0.379 0.019 DBMET00733 0.333 0.027 DBMET00540 0.428 0.013 DBMET02222 0.33 0.027 DBMET01018 0.44 0.012 DBMET01437 0.175 0.091 DBMET00507 | DBMET01437 | |
| 0.324 | 0.005 | 0.515 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.286 0.007 DBMET00733 0.288 0.007 DBMET00540 0.282 0.007 DBMET02222 0.223 0.013 DBMET01018 0.515 0.002 DBMET01437 0.207 0.015 DBMET00507 | DBMET01437 | |
| 0.387 | 0.071 | 0.885 | Antiobesity | 0.286 0.126 DBMET00733 0.885 0.005 DBMET00540 0.826 0.005 DBMET01018 | DBMET00540 | |
| 0.314 | 0.004 | 0.314 | 5 Hydroxytryptamine 2C agonist | 0.164 0.005 DBMET00733 0.114 0.006 DBMET00540 0.082 0.01 DBMET01018 | ||
| 0.413 | 0.104 | 0.621 | Caspase 9 stimulant | 0.481 0.068 DBMET00733 0.373 0.128 DBMET00540 0.621 0.033 DBMET02222 0.435 0.091 DBMET01018 0.462 0.077 DBMET01437 0.39 0.117 DBMET00507 | DBMET02222 | |
| 0.315 | 0.008 | 0.721 | GABA C receptor agonist | 0.302 0.009 DBMET00733 0.265 0.012 DBMET00540 0.275 0.011 DBMET02222 0.208 0.019 DBMET01018 0.721 0.002 DBMET01437 0.519 0.004 DBMET00507 | DBMET01437 | |
| 0.307 | 0.007 | 0.611 | Ferrochelatase inhibitor | 0.201 0.022 DBMET00733 0.388 0.004 DBMET00540 0.317 0.006 DBMET02222 0.26 0.012 DBMET01018 0.611 0.002 DBMET01437 0.351 0.005 DBMET00507 | DBMET01437 | |
| 0.305 | 0.006 | 0.462 | Histidine decarboxylase inhibitor | 0.428 0.004 DBMET00733 0.225 0.011 DBMET00540 0.245 0.009 DBMET02222 0.324 0.005 DBMET01018 0.462 0.003 DBMET01437 0.334 0.005 DBMET00507 | DBMET01437 | |
| 0.366 | 0.072 | 0.489 | Transcription factor NF kappa B inhibitor | 0.489 0.046 DBMET00733 0.367 0.072 DBMET00540 0.301 0.093 DBMET02222 0.465 0.05 DBMET01018 0.379 0.068 DBMET01437 0.251 0.127 DBMET00507 | DBMET00733 | |
| 0.302 | 0.008 | 0.302 | Aminopeptidase B inhibitor | 0.301 0.008 DBMET00733 0.234 0.015 DBMET00540 0.205 0.02 DBMET02222 0.218 0.018 DBMET01018 0.276 0.01 DBMET01437 0.248 0.013 DBMET00507 | ||
| 0.369 | 0.077 | 0.393 | Calpain 2 inhibitor | 0.307 0.11 DBMET00733 0.334 0.095 DBMET00540 0.393 0.065 DBMET02222 0.299 0.115 DBMET01018 0.309 0.108 DBMET01437 0.322 0.101 DBMET00507 | DBMET02222 | |
| 0.297 | 0.01 | 0.297 | Cathepsin H inhibitor | 0.245 0.014 DBMET00733 0.194 0.024 DBMET00540 0.208 0.02 DBMET02222 0.166 0.036 DBMET01018 0.226 0.017 DBMET01437 0.154 0.043 DBMET00507 | ||
| 0.35 | 0.064 | 0.67 | Cholesterol antagonist | 0.445 0.041 DBMET00733 0.39 0.051 DBMET00540 0.38 0.054 DBMET02222 0.447 0.041 DBMET01018 0.67 0.01 DBMET01437 0.422 0.045 DBMET00507 | DBMET01437 | |
| 0.31 | 0.027 | 0.381 | Gastrin inhibitor | 0.264 0.064 DBMET00733 0.254 0.074 DBMET00540 0.29 0.04 DBMET02222 0.194 0.158 DBMET01018 0.361 0.008 DBMET01437 0.381 0.005 DBMET00507 | DBMET00507 | |
| 0.323 | 0.041 | 0.352 | Angiogenesis stimulant | 0.352 0.032 DBMET00733 0.256 0.067 DBMET00540 0.292 0.052 DBMET01018 0.248 0.071 DBMET01437 0.281 0.057 DBMET00507 | DBMET00733 | |
| 0.28 | 0.003 | 0.28 | 5 Hydroxytryptamine 2A agonist | 0.263 0.003 DBMET00733 0.169 0.004 DBMET00540 0.181 0.004 DBMET01018 | ||
| 0.282 | 0.007 | 0.282 | 5 Hydroxytryptamine 3E antagonist | 0.227 0.03 DBMET00733 0.208 0.05 DBMET00540 0.25 0.016 DBMET02222 0.184 0.096 DBMET01018 0.215 0.041 DBMET01437 0.18 0.105 DBMET00507 | ||
| 0.302 | 0.029 | 0.302 | Calpain inhibitor | 0.284 0.039 DBMET00733 0.268 0.05 DBMET00540 0.273 0.046 DBMET02222 0.255 0.06 DBMET01018 0.227 0.088 DBMET01437 0.251 0.064 DBMET00507 | ||
| 0.337 | 0.068 | 0.417 | Immunostimulant | 0.378 0.056 DBMET00733 0.4 0.049 DBMET00540 0.232 0.104 DBMET02222 0.417 0.045 DBMET01018 0.274 0.087 DBMET01437 0.345 0.066 DBMET00507 | DBMET01018 | |
| 0.336 | 0.07 | 0.474 | Antithrombotic | 0.364 0.06 DBMET00733 0.439 0.04 DBMET00540 0.282 0.101 DBMET02222 0.438 0.04 DBMET01018 0.43 0.042 DBMET01437 0.474 0.033 DBMET00507 | DBMET00507 | |
| 0.304 | 0.038 | 0.304 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.23 0.071 DBMET00733 | ||
| 0.342 | 0.077 | 0.615 | Vasodilator, peripheral | 0.352 0.073 DBMET00733 0.615 0.014 DBMET00540 0.408 0.053 DBMET02222 0.608 0.015 DBMET01018 0.5 0.028 DBMET01437 0.224 0.149 DBMET00507 | DBMET00540 | |
| 0.28 | 0.017 | 0.364 | Nitric-oxide synthase stimulant | 0.305 0.01 DBMET00733 0.307 0.01 DBMET00540 0.263 0.024 DBMET02222 0.331 0.006 DBMET01018 0.271 0.021 DBMET01437 0.364 0.004 DBMET00507 | DBMET00507 | |
| 0.283 | 0.028 | 0.283 | Neuropeptide Y2 antagonist | 0.281 0.03 DBMET00733 0.28 0.031 DBMET00540 0.235 0.071 DBMET02222 0.279 0.031 DBMET01018 0.233 0.073 DBMET01437 0.209 0.104 DBMET00507 | ||
| 0.259 | 0.004 | 0.259 | Aminopeptidase I inhibitor | 0.248 0.004 DBMET00733 0.197 0.007 DBMET00540 0.16 0.011 DBMET02222 0.172 0.009 DBMET01018 0.23 0.005 DBMET01437 0.201 0.007 DBMET00507 | ||
| 0.26 | 0.019 | 0.293 | Neurotensin receptor agonist | 0.293 0.015 DBMET00733 0.178 0.052 DBMET00540 0.17 0.062 DBMET02222 0.2 0.035 DBMET01018 0.207 0.031 DBMET01437 0.205 0.032 DBMET00507 | DBMET00733 | |
| 0.315 | 0.077 | 0.429 | Calcium channel activator | 0.299 0.093 DBMET00733 0.361 0.043 DBMET00540 0.362 0.042 DBMET02222 0.35 0.049 DBMET01018 0.429 0.016 DBMET01437 0.282 0.111 DBMET00507 | DBMET01437 | |
| 0.23 | 0.004 | 0.314 | DOPA decarboxylase inhibitor | 0.314 0.002 DBMET00733 0.158 0.017 DBMET00540 0.221 0.005 DBMET02222 0.205 0.006 DBMET01018 0.249 0.004 DBMET01437 0.14 0.027 DBMET00507 | DBMET00733 | |
| 0.288 | 0.063 | 0.335 | Transcription factor STAT inhibitor | 0.319 0.046 DBMET00733 0.177 0.173 DBMET00540 0.182 0.164 DBMET02222 0.201 0.138 DBMET01018 0.335 0.04 DBMET01437 0.215 0.118 DBMET00507 | DBMET01437 | |
| 0.229 | 0.006 | 0.229 | Nitric-oxide synthase inhibitor | 0.178 0.014 DBMET00733 0.133 0.031 DBMET00540 0.138 0.028 DBMET02222 0.103 0.056 DBMET01018 | ||
| 0.323 | 0.101 | 0.36 | Immunosuppressant | 0.344 0.09 DBMET00733 0.306 0.111 DBMET00540 0.36 0.081 DBMET02222 0.304 0.112 DBMET01018 0.327 0.099 DBMET01437 0.24 0.157 DBMET00507 | DBMET02222 | |
| 0.253 | 0.033 | 0.278 | Insulin sensitizer | 0.273 0.023 DBMET00733 0.264 0.027 DBMET00540 0.183 0.092 DBMET02222 0.271 0.024 DBMET01018 0.278 0.022 DBMET01437 0.267 0.026 DBMET00507 | DBMET01437 | |
| 0.247 | 0.027 | 0.247 | Thiol protease inhibitor | 0.208 0.037 DBMET00733 0.175 0.051 DBMET00540 0.207 0.037 DBMET02222 0.146 0.072 DBMET01018 0.195 0.041 DBMET01437 0.185 0.046 DBMET00507 | ||
| 0.221 | 0.005 | 0.221 | CYP2A6 inhibitor | 0.152 0.016 DBMET00733 0.072 0.056 DBMET00540 0.188 0.009 DBMET02222 0.089 0.042 DBMET01437 | ||
| 0.271 | 0.055 | 0.404 | DNA synthesis inhibitor | 0.301 0.043 DBMET00733 0.308 0.041 DBMET00540 0.231 0.081 DBMET02222 0.315 0.039 DBMET01018 0.404 0.021 DBMET01437 0.309 0.041 DBMET00507 | DBMET01437 | |
| 0.242 | 0.027 | 0.397 | Phospholipase C inhibitor | 0.344 0.015 DBMET00733 0.213 0.037 DBMET00540 0.184 0.057 DBMET02222 0.242 0.027 DBMET01018 0.397 0.011 DBMET01437 0.355 0.014 DBMET00507 | DBMET01437 | |
| 0.226 | 0.011 | 0.277 | Catalase inhibitor | 0.222 0.012 DBMET00733 0.26 0.008 DBMET00540 0.238 0.01 DBMET02222 0.23 0.011 DBMET01018 0.277 0.007 DBMET01437 0.217 0.012 DBMET00507 | DBMET01437 | |
| 0.268 | 0.055 | 0.351 | Interleukin antagonist | 0.351 0.039 DBMET00733 0.223 0.073 DBMET00540 0.142 0.124 DBMET02222 0.296 0.049 DBMET01018 | DBMET00733 | |
| 0.214 | 0.006 | 0.558 | Glutamate decarboxylase inhibitor | 0.306 0.004 DBMET00733 0.335 0.003 DBMET00540 0.17 0.01 DBMET02222 0.469 0.003 DBMET01018 0.558 0.002 DBMET01437 0.265 0.004 DBMET00507 | DBMET01437 | |
| 0.268 | 0.063 | 0.365 | Antiamyloidogenic | 0.365 0.036 DBMET00733 0.197 0.102 DBMET01018 0.237 0.077 DBMET01437 0.171 0.122 DBMET00507 | DBMET00733 | |
| 0.271 | 0.069 | 0.336 | Transcription factor STAT3 inhibitor | 0.3 0.053 DBMET00733 0.196 0.139 DBMET02222 0.182 0.162 DBMET01018 0.336 0.038 DBMET01437 0.233 0.098 DBMET00507 | DBMET01437 | |
| 0.243 | 0.042 | 0.324 | Neurotrophic factor enhancer | 0.296 0.019 DBMET00733 0.215 0.063 DBMET00540 0.324 0.013 DBMET02222 0.256 0.035 DBMET01018 0.259 0.034 DBMET01437 0.265 0.031 DBMET00507 | DBMET02222 | |
| 0.21 | 0.01 | 0.256 | Adenylate cyclase stimulant | 0.238 0.005 DBMET00733 0.237 0.005 DBMET00540 0.18 0.025 DBMET02222 0.256 0.004 DBMET01018 0.186 0.022 DBMET01437 0.184 0.023 DBMET00507 | DBMET01018 | |
| 0.208 | 0.008 | 0.243 | Prolactin inhibitor | 0.243 0.005 DBMET00733 0.126 0.034 DBMET00540 0.152 0.021 DBMET02222 0.15 0.022 DBMET01018 0.171 0.015 DBMET01437 0.125 0.035 DBMET00507 | DBMET00733 | |
| 0.203 | 0.004 | 0.203 | 5 Hydroxytryptamine 2 agonist | 0.129 0.006 DBMET00733 0.112 0.008 DBMET00540 0.093 0.011 DBMET01018 | ||
| 0.206 | 0.007 | 0.319 | Argininosuccinate synthase inhibitor | 0.184 0.009 DBMET00733 0.21 0.007 DBMET00540 0.193 0.008 DBMET02222 0.162 0.01 DBMET01018 0.319 0.004 DBMET01437 0.131 0.014 DBMET00507 | DBMET01437 | |
| 0.261 | 0.063 | 0.261 | 5 Hydroxytryptamine 1E antagonist | 0.252 0.072 DBMET00733 0.192 0.14 DBMET00540 0.247 0.077 DBMET02222 0.205 0.125 DBMET01018 0.216 0.113 DBMET01437 | ||
| 0.211 | 0.015 | 0.211 | Falcipain 3 inhibitor | 0.198 0.018 DBMET00733 0.104 0.066 DBMET00540 0.172 0.027 DBMET02222 0.093 0.078 DBMET01018 0.174 0.027 DBMET01437 0.176 0.026 DBMET00507 | ||
| 0.247 | 0.053 | 0.571 | Peptidyltransferase inhibitor | 0.276 0.035 DBMET00733 0.571 0.003 DBMET00540 0.534 0.003 DBMET01018 0.235 0.062 DBMET01437 0.349 0.012 DBMET00507 | DBMET00540 | |
| 0.199 | 0.013 | 0.332 | GABA C receptor antagonist | 0.194 0.014 DBMET00733 0.167 0.022 DBMET00540 0.17 0.021 DBMET02222 0.15 0.03 DBMET01018 0.332 0.004 DBMET01437 0.276 0.005 DBMET00507 | DBMET01437 | |
| 0.195 | 0.012 | 0.241 | Opioid delta receptor antagonist | 0.241 0.006 DBMET00733 0.069 0.041 DBMET00540 0.142 0.021 DBMET01018 | DBMET00733 | |
| 0.194 | 0.014 | 0.231 | Sphingosine 1-phosphate receptor 5 antagonist | 0.192 0.015 DBMET00733 0.149 0.062 DBMET00540 0.181 0.023 DBMET02222 0.138 0.084 DBMET01018 0.231 0.005 DBMET01437 0.154 0.055 DBMET00507 | DBMET01437 | |
| 0.211 | 0.031 | 0.211 | Nav1.2 sodium channel blocker | 0.163 0.05 DBMET00733 0.124 0.079 DBMET00540 0.117 0.087 DBMET01437 0.147 0.059 DBMET00507 | ||
| 0.194 | 0.015 | 0.247 | Opioid antagonist | 0.247 0.008 DBMET00733 0.083 0.066 DBMET00540 0.135 0.03 DBMET01018 | DBMET00733 | |
| 0.19 | 0.012 | 0.413 | Creatine kinase inhibitor | 0.313 0.004 DBMET00733 0.193 0.012 DBMET00540 0.174 0.016 DBMET02222 0.277 0.005 DBMET01018 0.413 0.003 DBMET01437 0.155 0.022 DBMET00507 | DBMET01437 | |
| 0.215 | 0.038 | 0.593 | Succinate dehydrogenase inhibitor | 0.23 0.03 DBMET00733 0.226 0.032 DBMET00540 0.332 0.007 DBMET02222 0.219 0.036 DBMET01018 0.593 0.003 DBMET01437 0.308 0.009 DBMET00507 | DBMET01437 | |
| 0.204 | 0.029 | 0.204 | Histone deacetylase SIRT1 inhibitor | 0.192 0.033 DBMET00733 0.115 0.097 DBMET01018 0.114 0.099 DBMET01437 0.174 0.044 DBMET00507 | ||
| 0.184 | 0.011 | 0.492 | Glutamate dehydrogenase inhibitor | 0.181 0.012 DBMET00733 0.212 0.009 DBMET00540 0.178 0.012 DBMET02222 0.176 0.012 DBMET01018 0.492 0.003 DBMET01437 0.228 0.008 DBMET00507 | DBMET01437 | |
| 0.217 | 0.044 | 0.282 | Thrombolytic | 0.22 0.043 DBMET00733 0.169 0.068 DBMET00540 0.169 0.068 DBMET01018 0.222 0.042 DBMET01437 0.282 0.027 DBMET00507 | DBMET00507 | |
| 0.189 | 0.017 | 0.39 | Adenylate kinase inhibitor | 0.168 0.021 DBMET00733 0.247 0.01 DBMET00540 0.25 0.01 DBMET02222 0.193 0.016 DBMET01018 0.39 0.003 DBMET01437 0.254 0.01 DBMET00507 | DBMET01437 | |
| 0.204 | 0.031 | 0.307 | Anesthetic local | 0.169 0.041 DBMET00733 0.307 0.012 DBMET00540 0.14 0.054 DBMET02222 0.276 0.015 DBMET01018 0.202 0.032 DBMET01437 0.094 0.089 DBMET00507 | DBMET00540 | |
| 0.197 | 0.025 | 0.423 | Cystathionine beta-synthase inhibitor | 0.319 0.008 DBMET00733 0.171 0.032 DBMET00540 0.186 0.028 DBMET02222 0.254 0.015 DBMET01018 0.423 0.004 DBMET01437 0.158 0.037 DBMET00507 | DBMET01437 | |
| 0.18 | 0.009 | 0.183 | Somatostatin 1 agonist | 0.178 0.009 DBMET00733 0.181 0.008 DBMET00540 0.183 0.008 DBMET01018 0.083 0.048 DBMET01437 | DBMET01018 | |
| 0.233 | 0.062 | 0.349 | RNA-directed DNA polymerase inhibitor | 0.249 0.05 DBMET00733 0.222 0.072 DBMET00540 0.215 0.08 DBMET02222 0.226 0.068 DBMET01018 0.349 0.024 DBMET01437 0.176 0.14 DBMET00507 | DBMET01437 | |
| 0.176 | 0.006 | 0.176 | Protein kinase C iota inhibitor | 0.113 0.015 DBMET00733 0.055 0.046 DBMET00540 | ||
| 0.186 | 0.019 | 0.322 | Carbonic anhydrase III inhibitor | 0.281 0.006 DBMET00733 0.167 0.023 DBMET00540 0.133 0.036 DBMET02222 0.241 0.01 DBMET01018 0.322 0.005 DBMET01437 0.133 0.036 DBMET00507 | DBMET01437 | |
| 0.179 | 0.012 | 0.304 | GABA C receptor rho-1 antagonist | 0.162 0.017 DBMET00733 0.146 0.023 DBMET00540 0.158 0.018 DBMET02222 0.125 0.036 DBMET01018 0.304 0.003 DBMET01437 0.268 0.004 DBMET00507 | DBMET01437 | |
| 0.205 | 0.04 | 0.237 | Acetylcholine M1 receptor antagonist | 0.201 0.042 DBMET00733 0.237 0.029 DBMET00540 0.148 0.076 DBMET02222 0.235 0.029 DBMET01018 0.148 0.076 DBMET01437 | DBMET00540 | |
| 0.188 | 0.024 | 0.24 | Cyclooxygenase 3 inhibitor | 0.206 0.017 DBMET00733 0.188 0.023 DBMET00540 0.176 0.03 DBMET02222 0.204 0.017 DBMET01018 0.24 0.01 DBMET01437 0.158 0.042 DBMET00507 | DBMET01437 | |
| 0.174 | 0.012 | 0.174 | Inducible nitric-oxide synthase inhibitor | 0.135 0.02 DBMET00733 0.123 0.024 DBMET00540 0.137 0.019 DBMET02222 0.102 0.035 DBMET01018 0.081 0.06 DBMET01437 | ||
| 0.178 | 0.016 | 0.198 | Sphingosine 1-phosphate receptor 2 antagonist | 0.178 0.016 DBMET00733 0.154 0.035 DBMET00540 0.163 0.027 DBMET02222 0.149 0.042 DBMET01018 0.198 0.008 DBMET01437 0.153 0.037 DBMET00507 | DBMET01437 | |
| 0.191 | 0.031 | 0.259 | MAO A inhibitor | 0.259 0.02 DBMET00733 | DBMET00733 | |
| 0.176 | 0.016 | 0.2 | Sphingosine 1-phosphate receptor 4 antagonist | 0.16 0.025 DBMET00733 0.124 0.066 DBMET00540 0.194 0.01 DBMET02222 0.107 0.102 DBMET01018 0.2 0.009 DBMET01437 0.13 0.056 DBMET00507 | DBMET01437 | |
| 0.207 | 0.048 | 0.207 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.164 0.068 DBMET00733 | ||
| 0.182 | 0.023 | 0.187 | Nav1.4 sodium channel blocker | 0.185 0.023 DBMET00733 0.18 0.024 DBMET00540 0.187 0.022 DBMET01018 | DBMET01018 | |
| 0.206 | 0.048 | 0.312 | 3C-like protease (Human coronavirus) inhibitor | 0.158 0.088 DBMET00733 0.231 0.036 DBMET02222 0.312 0.009 DBMET01437 0.198 0.053 DBMET00507 | DBMET01437 | |
| 0.176 | 0.018 | 0.176 | Cathepsin G inhibitor | 0.169 0.019 DBMET00733 0.135 0.024 DBMET00540 0.1 0.033 DBMET02222 0.128 0.025 DBMET01018 0.151 0.021 DBMET01437 0.147 0.022 DBMET00507 | ||
| 0.186 | 0.03 | 0.186 | Proteasome inhibitor | 0.181 0.032 DBMET00733 0.148 0.048 DBMET00540 0.169 0.036 DBMET02222 0.145 0.05 DBMET01018 0.106 0.079 DBMET01437 0.15 0.047 DBMET00507 | ||
| 0.175 | 0.021 | 0.264 | Mucolytic | 0.205 0.012 DBMET00733 0.238 0.008 DBMET00540 0.173 0.021 DBMET02222 0.255 0.006 DBMET01018 0.237 0.008 DBMET01437 0.264 0.005 DBMET00507 | DBMET00507 | |
| 0.168 | 0.014 | 0.218 | Opioid mu receptor antagonist | 0.218 0.007 DBMET00733 0.063 0.051 DBMET00540 0.12 0.025 DBMET01018 | DBMET00733 | |
| 0.159 | 0.006 | 0.421 | GABA aminotransferase inhibitor | 0.201 0.004 DBMET00733 0.119 0.016 DBMET00540 0.109 0.021 DBMET02222 0.131 0.012 DBMET01018 0.421 0.003 DBMET01437 0.134 0.011 DBMET00507 | DBMET01437 | |
| 0.174 | 0.021 | 0.187 | Interleukin 8 antagonist | 0.187 0.016 DBMET00733 0.13 0.05 DBMET02222 0.16 0.028 DBMET01437 0.103 0.09 DBMET00507 | DBMET00733 | |
| 0.175 | 0.023 | 0.378 | Carbonic anhydrase XV inhibitor | 0.249 0.012 DBMET00733 0.148 0.031 DBMET00540 0.165 0.026 DBMET02222 0.196 0.019 DBMET01018 0.378 0.004 DBMET01437 0.109 0.056 DBMET00507 | DBMET01437 | |
| 0.173 | 0.022 | 0.196 | Vanilloid 1 agonist | 0.196 0.013 DBMET00733 0.133 0.061 DBMET00540 0.164 0.027 DBMET02222 0.144 0.044 DBMET01018 0.148 0.041 DBMET01437 0.167 0.025 DBMET00507 | DBMET00733 | |
| 0.153 | 0.003 | 0.153 | 5 Hydroxytryptamine 2B agonist | 0.088 0.004 DBMET00733 0.092 0.004 DBMET00540 0.071 0.006 DBMET01018 | ||
| 0.179 | 0.031 | 0.179 | 5 Hydroxytryptamine 2B antagonist | 0.128 0.053 DBMET00733 | ||
| 0.186 | 0.039 | 0.225 | Hemostatic | 0.187 0.038 DBMET00733 0.132 0.092 DBMET00540 0.131 0.095 DBMET01018 0.213 0.028 DBMET01437 0.225 0.025 DBMET00507 | DBMET00507 | |
| 0.19 | 0.044 | 0.245 | MAO inhibitor | 0.245 0.029 DBMET00733 0.101 0.09 DBMET02222 | DBMET00733 | |
| 0.166 | 0.021 | 0.221 | Heat shock protein 70 antagonist | 0.18 0.012 DBMET00733 0.142 0.066 DBMET00540 0.142 0.067 DBMET02222 0.151 0.044 DBMET01018 0.221 0.005 DBMET01437 0.146 0.055 DBMET00507 | DBMET01437 | |
| 0.179 | 0.034 | 0.234 | Toll-Like receptor 2 antagonist | 0.224 0.015 DBMET00733 0.152 0.051 DBMET00540 0.147 0.054 DBMET02222 0.189 0.029 DBMET01018 0.207 0.021 DBMET01437 0.234 0.012 DBMET00507 | DBMET00507 | |
| 0.156 | 0.012 | 0.159 | Histamine N-methyltransferase inhibitor | 0.148 0.015 DBMET00733 0.093 0.053 DBMET00540 0.115 0.033 DBMET02222 0.09 0.056 DBMET01018 0.159 0.011 DBMET01437 | DBMET01437 | |
| 0.176 | 0.033 | 0.179 | Neuropeptide Y1 antagonist | 0.179 0.031 DBMET00733 0.124 0.114 DBMET01018 0.146 0.071 DBMET01437 | DBMET00733 | |
| 0.166 | 0.023 | 0.209 | Photosensitizer | 0.169 0.022 DBMET00733 0.149 0.031 DBMET00540 0.177 0.019 DBMET02222 0.147 0.033 DBMET01018 0.209 0.011 DBMET01437 0.147 0.033 DBMET00507 | DBMET01437 | |
| 0.161 | 0.018 | 0.765 | Porphobilinogen synthase inhibitor | 0.213 0.011 DBMET00733 0.136 0.024 DBMET00540 0.411 0.004 DBMET02222 0.151 0.02 DBMET01018 0.765 0.002 DBMET01437 0.336 0.005 DBMET00507 | DBMET01437 | |
| 0.173 | 0.033 | 0.276 | Adenylate cyclase inhibitor | 0.203 0.025 DBMET00733 0.256 0.018 DBMET00540 0.111 0.075 DBMET02222 0.273 0.017 DBMET01018 0.199 0.026 DBMET01437 0.276 0.016 DBMET00507 | DBMET00507 | |
| 0.157 | 0.019 | 0.165 | Transcription factor STAT6 inhibitor | 0.165 0.015 DBMET00733 0.14 0.032 DBMET00540 0.113 0.073 DBMET02222 0.147 0.026 DBMET01018 0.134 0.039 DBMET01437 0.112 0.075 DBMET00507 | DBMET00733 | |
| 0.142 | 0.007 | 0.155 | Granulocyte macrophage colony stimulating factor agonist | 0.138 0.008 DBMET00733 0.12 0.016 DBMET00540 0.124 0.013 DBMET02222 0.117 0.018 DBMET01018 0.155 0.005 DBMET01437 0.132 0.01 DBMET00507 | DBMET01437 | |
| 0.142 | 0.007 | 0.142 | Protease 3C (Human rhinovirus) inhibitor | 0.113 0.011 DBMET00733 0.07 0.037 DBMET00540 0.116 0.011 DBMET02222 0.061 0.051 DBMET01018 0.083 0.025 DBMET01437 0.085 0.023 DBMET00507 | ||
| 0.148 | 0.015 | 0.357 | Adrenaline agonist | 0.22 0.005 DBMET00733 0.294 0.004 DBMET00540 0.357 0.003 DBMET01018 0.117 0.027 DBMET01437 0.088 0.047 DBMET00507 | DBMET01018 | |
| 0.158 | 0.026 | 0.229 | Ca2+-transporting ATPase inhibitor | 0.158 0.027 DBMET00733 0.169 0.014 DBMET00540 0.171 0.012 DBMET02222 0.164 0.019 DBMET01018 0.229 0.002 DBMET01437 0.156 0.031 DBMET00507 | DBMET01437 | |
| 0.158 | 0.026 | 0.158 | Protease inhibitor | 0.136 0.037 DBMET00733 0.098 0.067 DBMET00540 0.117 0.05 DBMET02222 0.083 0.082 DBMET00507 | ||
| 0.182 | 0.049 | 0.295 | Interferon gamma antagonist | 0.238 0.031 DBMET00733 0.175 0.054 DBMET00540 0.168 0.059 DBMET02222 0.205 0.039 DBMET01018 0.295 0.021 DBMET01437 0.138 0.095 DBMET00507 | DBMET01437 | |
| 0.141 | 0.012 | 0.166 | Carbonic anhydrase stimulant | 0.108 0.017 DBMET00733 0.166 0.01 DBMET00540 0.058 0.043 DBMET02222 0.121 0.014 DBMET01018 0.074 0.029 DBMET01437 0.119 0.014 DBMET00507 | DBMET00540 | |
| 0.18 | 0.051 | 0.313 | Melanin inhibitor | 0.3 0.022 DBMET00733 0.203 0.04 DBMET00540 0.225 0.033 DBMET02222 0.313 0.02 DBMET01018 0.21 0.037 DBMET01437 0.161 0.068 DBMET00507 | DBMET01018 | |
| 0.144 | 0.016 | 0.187 | Analgesic, opioid | 0.187 0.01 DBMET00733 0.071 0.061 DBMET02222 0.088 0.039 DBMET01018 | DBMET00733 | |
| 0.14 | 0.012 | 0.169 | Carbamoyl phosphate synthetase inhibitor | 0.132 0.013 DBMET00733 0.164 0.01 DBMET00540 0.113 0.017 DBMET02222 0.134 0.013 DBMET01018 0.169 0.009 DBMET01437 0.127 0.014 DBMET00507 | DBMET01437 | |
| 0.166 | 0.038 | 0.166 | Nav1.6 sodium channel blocker | 0.138 0.07 DBMET00733 0.117 0.101 DBMET00540 0.119 0.097 DBMET02222 0.136 0.072 DBMET01437 | ||
| 0.137 | 0.011 | 0.137 | Adrenaline uptake inhibitor | 0.081 0.026 DBMET00733 | ||
| 0.173 | 0.048 | 0.289 | GABA C receptor rho-2 antagonist | 0.166 0.055 DBMET00733 0.13 0.105 DBMET00540 0.219 0.02 DBMET02222 0.126 0.113 DBMET01018 0.282 0.007 DBMET01437 0.289 0.006 DBMET00507 | DBMET00507 | |
| 0.14 | 0.014 | 0.214 | Ornithine decarboxylase inhibitor | 0.149 0.011 DBMET00733 0.158 0.009 DBMET00540 0.118 0.027 DBMET02222 0.158 0.009 DBMET01018 0.214 0.004 DBMET01437 0.127 0.021 DBMET00507 | DBMET01437 | |
| 0.13 | 0.005 | 0.238 | Glutamate (mGluR6) antagonist | 0.112 0.007 DBMET00733 0.148 0.004 DBMET00540 0.089 0.016 DBMET02222 0.114 0.006 DBMET01018 0.238 0.002 DBMET01437 0.09 0.015 DBMET00507 | DBMET01437 | |
| 0.14 | 0.016 | 0.157 | Lanosterol 14 alpha demethylase inhibitor | 0.135 0.018 DBMET00733 0.135 0.018 DBMET00540 0.157 0.009 DBMET02222 0.128 0.023 DBMET01018 0.136 0.018 DBMET01437 0.133 0.02 DBMET00507 | DBMET02222 | |
| 0.144 | 0.021 | 0.144 | Factor V inhibitor | 0.123 0.036 DBMET00733 0.12 0.038 DBMET00540 0.106 0.058 DBMET01018 0.13 0.03 DBMET01437 0.099 0.07 DBMET00507 | ||
| 0.162 | 0.04 | 0.244 | Cell adhesion inhibitor | 0.134 0.056 DBMET00733 0.106 0.08 DBMET02222 0.178 0.032 DBMET01437 0.244 0.016 DBMET00507 | DBMET00507 | |
| 0.155 | 0.033 | 0.274 | Expectorant | 0.199 0.02 DBMET00733 0.244 0.013 DBMET00540 0.148 0.036 DBMET02222 0.274 0.01 DBMET01018 0.25 0.013 DBMET01437 0.251 0.013 DBMET00507 | DBMET01018 | |
| 0.134 | 0.012 | 0.169 | Sphingosine 1-phosphate receptor 4 agonist | 0.125 0.015 DBMET00733 0.123 0.015 DBMET00540 0.083 0.035 DBMET02222 0.105 0.023 DBMET01018 0.118 0.017 DBMET01437 0.169 0.006 DBMET00507 | DBMET00507 | |
| 0.196 | 0.075 | 0.303 | Non-steroidal antiinflammatory agent | 0.207 0.066 DBMET00733 0.201 0.07 DBMET02222 0.303 0.027 DBMET01437 0.196 0.075 DBMET00507 | DBMET01437 | |
| 0.138 | 0.017 | 0.149 | Glutamate (mGluR7) agonist | 0.1 0.06 DBMET00733 0.149 0.012 DBMET00540 0.109 0.045 DBMET02222 0.114 0.037 DBMET01018 0.137 0.018 DBMET01437 0.142 0.015 DBMET00507 | DBMET00540 | |
| 0.125 | 0.004 | 0.139 | Sphingosine kinase 2 inhibitor | 0.139 0.004 DBMET00733 0.101 0.007 DBMET00540 0.076 0.018 DBMET02222 0.104 0.007 DBMET01018 0.062 0.029 DBMET01437 | DBMET00733 | |
| 0.158 | 0.038 | 0.158 | Histone deacetylase class III inhibitor | 0.149 0.044 DBMET00733 0.135 0.057 DBMET00507 | ||
| 0.131 | 0.011 | 0.219 | Ornithine carbamoyltransferase inhibitor | 0.107 0.015 DBMET00733 0.145 0.01 DBMET00540 0.054 0.036 DBMET02222 0.1 0.016 DBMET01018 0.219 0.006 DBMET01437 0.128 0.012 DBMET00507 | DBMET01437 | |
| 0.138 | 0.02 | 0.138 | Chymotrypsin inhibitor | 0.106 0.032 DBMET00733 0.124 0.024 DBMET02222 0.081 0.053 DBMET01437 0.083 0.051 DBMET00507 | ||
| 0.145 | 0.027 | 0.218 | Sphingomyelinase inhibitor | 0.123 0.039 DBMET00733 0.218 0.007 DBMET00540 0.129 0.035 DBMET02222 0.189 0.012 DBMET01018 0.127 0.036 DBMET01437 0.117 0.043 DBMET00507 | DBMET00540 | |
| 0.144 | 0.028 | 0.261 | HIV-1 integrase (Overall Integration) inhibitor | 0.156 0.023 DBMET00733 0.192 0.013 DBMET00540 0.192 0.013 DBMET02222 0.185 0.015 DBMET01018 0.261 0.004 DBMET01437 0.234 0.006 DBMET00507 | DBMET01437 | |
| 0.124 | 0.009 | 0.174 | Opioid mu receptor agonist | 0.174 0.005 DBMET00733 0.042 0.037 DBMET00540 0.076 0.019 DBMET01018 | DBMET00733 | |
| 0.127 | 0.013 | 0.915 | Alcohol oxidase inhibitor | 0.275 0.005 DBMET00733 0.177 0.008 DBMET00540 0.156 0.01 DBMET02222 0.29 0.005 DBMET01018 0.915 0.002 DBMET01437 0.191 0.007 DBMET00507 | DBMET01437 | |
| 0.125 | 0.012 | 0.125 | Bombesin 1 receptor agonist | 0.096 0.019 DBMET00733 0.053 0.05 DBMET00540 | ||
| 0.192 | 0.079 | 0.363 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.247 0.044 DBMET00733 0.246 0.044 DBMET00540 0.246 0.044 DBMET02222 0.285 0.029 DBMET01018 0.363 0.011 DBMET01437 0.273 0.033 DBMET00507 | DBMET01437 | |
| 0.135 | 0.024 | 0.188 | Aminoacyl-tRNA synthetase inhibitor | 0.137 0.023 DBMET00733 0.188 0.012 DBMET00540 0.175 0.014 DBMET01018 0.086 0.065 DBMET01437 0.088 0.063 DBMET00507 | DBMET00540 | |
| 0.136 | 0.024 | 0.589 | Triose-phosphate isomerase inhibitor | 0.129 0.028 DBMET00733 0.184 0.013 DBMET00540 0.226 0.008 DBMET02222 0.149 0.02 DBMET01018 0.589 0.002 DBMET01437 0.245 0.007 DBMET00507 | DBMET01437 | |
| 0.175 | 0.063 | 0.287 | Anticoagulant | 0.135 0.094 DBMET00733 0.13 0.1 DBMET02222 0.121 0.11 DBMET01437 0.287 0.031 DBMET00507 | DBMET00507 | |
| 0.117 | 0.005 | 0.134 | Sphingosine kinase inhibitor | 0.134 0.004 DBMET00733 0.088 0.012 DBMET00540 0.07 0.025 DBMET02222 0.091 0.01 DBMET01018 0.062 0.035 DBMET01437 0.054 0.05 DBMET00507 | DBMET00733 | |
| 0.124 | 0.012 | 0.218 | NMDA receptor agonist | 0.107 0.017 DBMET00733 0.137 0.01 DBMET00540 0.057 0.051 DBMET02222 0.101 0.019 DBMET01018 0.218 0.004 DBMET01437 0.165 0.006 DBMET00507 | DBMET01437 | |
| 0.212 | 0.101 | 0.392 | Hypoglycemic | 0.309 0.05 DBMET00733 0.264 0.069 DBMET00540 0.322 0.046 DBMET01018 0.392 0.029 DBMET01437 0.284 0.059 DBMET00507 | DBMET01437 | |
| 0.133 | 0.022 | 0.29 | Phosphofructokinase-1 inhibitor | 0.147 0.019 DBMET00733 0.141 0.02 DBMET00540 0.15 0.018 DBMET02222 0.134 0.022 DBMET01018 0.29 0.006 DBMET01437 0.135 0.021 DBMET00507 | DBMET01437 | |
| 0.17 | 0.061 | 0.286 | Diuretic | 0.151 0.077 DBMET00733 0.164 0.066 DBMET00540 0.275 0.027 DBMET02222 0.133 0.092 DBMET01018 0.286 0.025 DBMET01437 0.285 0.025 DBMET00507 | DBMET01437 | |
| 0.114 | 0.004 | 0.252 | Glutamate (mGluR3) antagonist | 0.101 0.004 DBMET00733 0.059 0.009 DBMET00540 0.042 0.019 DBMET02222 0.046 0.015 DBMET01018 0.252 0.003 DBMET01437 0.038 0.024 DBMET00507 | DBMET01437 | |
| 0.122 | 0.013 | 0.122 | Aminopeptidase microsomal inhibitor | 0.096 0.019 DBMET00733 0.098 0.018 DBMET00540 0.083 0.024 DBMET01018 0.06 0.039 DBMET00507 | ||
| 0.121 | 0.012 | 0.208 | Glycine receptor agonist | 0.12 0.013 DBMET00733 0.118 0.013 DBMET00540 0.095 0.024 DBMET02222 0.108 0.017 DBMET01018 0.208 0.004 DBMET01437 0.112 0.015 DBMET00507 | DBMET01437 | |
| 0.113 | 0.005 | 0.132 | Glutamate (mGluR7) antagonist | 0.106 0.008 DBMET00733 0.098 0.012 DBMET00540 0.099 0.011 DBMET02222 0.091 0.016 DBMET01018 0.132 0.004 DBMET01437 0.073 0.038 DBMET00507 | DBMET01437 | |
| 0.118 | 0.011 | 0.118 | Secretase beta inhibitor | 0.095 0.021 DBMET00733 0.091 0.024 DBMET00540 0.075 0.042 DBMET01018 | ||
| 0.13 | 0.024 | 0.475 | NADH dehydrogenase inhibitor | 0.142 0.02 DBMET00733 0.156 0.016 DBMET00540 0.125 0.026 DBMET02222 0.154 0.017 DBMET01018 0.475 0.003 DBMET01437 0.199 0.01 DBMET00507 | DBMET01437 | |
| 0.135 | 0.031 | 0.135 | 5 Hydroxytryptamine 2C antagonist | 0.081 0.06 DBMET00733 | ||
| 0.106 | 0.004 | 0.106 | Immunoglobulin Fc receptor antagonist | 0.091 0.004 DBMET00733 0.064 0.017 DBMET00540 0.074 0.009 DBMET02222 0.058 0.029 DBMET01018 0.073 0.009 DBMET01437 0.054 0.043 DBMET00507 | ||
| 0.169 | 0.067 | 0.232 | Arachidonic acid antagonist | 0.184 0.05 DBMET00733 0.158 0.079 DBMET00540 0.226 0.013 DBMET02222 0.165 0.071 DBMET01018 0.232 0.011 DBMET01437 0.194 0.039 DBMET00507 | DBMET01437 | |
| 0.122 | 0.02 | 0.165 | Glutamate release inhibitor | 0.114 0.026 DBMET00733 0.131 0.016 DBMET00540 0.123 0.02 DBMET02222 0.125 0.019 DBMET01018 0.165 0.007 DBMET01437 0.092 0.057 DBMET00507 | DBMET01437 | |
| 0.12 | 0.018 | 0.12 | Protein kinase B alpha inhibitor | |||
| 0.132 | 0.03 | 0.234 | NMDA receptor antagonist | 0.212 0.013 DBMET00733 0.172 0.019 DBMET00540 0.234 0.01 DBMET01018 0.172 0.019 DBMET01437 0.091 0.053 DBMET00507 | DBMET01018 | |
| 0.131 | 0.03 | 0.162 | Anabolic | 0.149 0.018 DBMET00733 0.15 0.018 DBMET00540 0.154 0.016 DBMET02222 0.16 0.013 DBMET01018 0.162 0.013 DBMET01437 0.126 0.034 DBMET00507 | DBMET01437 | |
| 0.104 | 0.003 | 0.104 | Kainate receptor agonist | 0.098 0.003 DBMET00733 0.08 0.004 DBMET00540 0.054 0.01 DBMET02222 0.068 0.005 DBMET01018 0.092 0.003 DBMET01437 0.057 0.008 DBMET00507 | ||
| 0.122 | 0.022 | 0.122 | Neuropeptide agonist | 0.107 0.025 DBMET00733 0.107 0.025 DBMET00540 0.1 0.027 DBMET01018 | ||
| 0.135 | 0.035 | 0.469 | UDP-glucose 4-epimerase inhibitor | 0.148 0.029 DBMET00733 0.144 0.031 DBMET00540 0.356 0.008 DBMET02222 0.141 0.032 DBMET01018 0.469 0.003 DBMET01437 0.15 0.029 DBMET00507 | DBMET01437 | |
| 0.162 | 0.064 | 0.292 | Phospholipase A2 inhibitor | 0.195 0.045 DBMET00733 0.16 0.065 DBMET00540 0.226 0.031 DBMET02222 0.175 0.057 DBMET01018 0.292 0.015 DBMET01437 0.208 0.038 DBMET00507 | DBMET01437 | |
| 0.14 | 0.041 | 0.14 | 5 Hydroxytryptamine 3A agonist | 0.119 0.056 DBMET00733 0.134 0.045 DBMET02222 0.113 0.062 DBMET01437 | ||
| 0.107 | 0.01 | 0.107 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.084 0.03 DBMET00733 0.091 0.021 DBMET00540 0.089 0.024 DBMET02222 0.072 0.055 DBMET01018 0.105 0.01 DBMET01437 0.09 0.022 DBMET00507 | ||
| 0.113 | 0.015 | 0.426 | Biliverdin reductase inhibitor | 0.086 0.023 DBMET00733 0.124 0.013 DBMET00540 0.119 0.014 DBMET02222 0.079 0.026 DBMET01018 0.426 0.002 DBMET01437 0.178 0.007 DBMET00507 | DBMET01437 | |
| 0.121 | 0.025 | 0.121 | Protein kinase B gamma inhibitor | |||
| 0.108 | 0.012 | 0.291 | Glycine transporter 2 inhibitor | 0.154 0.007 DBMET00733 0.057 0.026 DBMET00540 0.075 0.019 DBMET01018 0.291 0.004 DBMET00507 | DBMET00507 | |
| 0.185 | 0.089 | 0.314 | DNA methylase inhibitor | 0.223 0.064 DBMET00733 0.177 0.095 DBMET02222 0.314 0.024 DBMET01437 0.26 0.043 DBMET00507 | DBMET01437 | |
| 0.1 | 0.004 | 0.114 | Glutamate (mGluR1) agonist | 0.063 0.004 DBMET00733 0.033 0.008 DBMET00540 0.023 0.022 DBMET02222 0.026 0.015 DBMET01018 0.114 0.003 DBMET01437 0.039 0.005 DBMET00507 | DBMET01437 | |
| 0.106 | 0.01 | 0.106 | Dopamine transporter inhibitor | 0.066 0.022 DBMET00733 | ||
| 0.101 | 0.005 | 0.181 | Glutamate (mGluR4) antagonist | 0.072 0.01 DBMET00733 0.048 0.023 DBMET00540 0.041 0.035 DBMET02222 0.181 0.003 DBMET01437 0.055 0.016 DBMET00507 | DBMET01437 | |
| 0.129 | 0.035 | 0.187 | Acetylcholine release stimulant | 0.099 0.089 DBMET00733 0.104 0.078 DBMET00540 0.187 0.005 DBMET02222 0.133 0.03 DBMET01437 0.1 0.088 DBMET00507 | DBMET02222 | |
| 0.097 | 0.004 | 0.097 | Histamine H2 receptor agonist | 0.058 0.016 DBMET00733 0.044 0.028 DBMET00540 0.057 0.016 DBMET02222 | ||
| 0.097 | 0.004 | 0.097 | Dipeptidyl peptidase I inhibitor | 0.043 0.011 DBMET00733 | ||
| 0.137 | 0.045 | 0.189 | Microtubule formation inhibitor | 0.135 0.046 DBMET00733 0.15 0.038 DBMET00540 0.155 0.035 DBMET02222 0.141 0.043 DBMET01018 0.189 0.022 DBMET01437 0.152 0.037 DBMET00507 | DBMET01437 | |
| 0.204 | 0.112 | 0.231 | DNA damaging | 0.214 0.105 DBMET00733 0.166 0.15 DBMET01018 0.226 0.095 DBMET01437 0.231 0.092 DBMET00507 | DBMET00507 | |
| 0.1 | 0.009 | 0.1 | Dipeptidyl peptidase inhibitor | 0.055 0.033 DBMET00733 | ||
| 0.103 | 0.012 | 0.103 | Aminopeptidase N inhibitor | 0.073 0.019 DBMET00733 0.068 0.021 DBMET00540 0.054 0.028 DBMET01018 0.043 0.038 DBMET00507 | ||
| 0.143 | 0.052 | 0.419 | Aldehyde dehydrogenase inhibitor | 0.206 0.026 DBMET00733 0.116 0.075 DBMET00540 0.256 0.017 DBMET02222 0.149 0.048 DBMET01018 0.419 0.005 DBMET01437 0.305 0.011 DBMET00507 | DBMET01437 | |
| 0.156 | 0.066 | 0.185 | CF transmembrane conductance regulator agonist | 0.185 0.032 DBMET00733 0.161 0.058 DBMET02222 0.146 0.083 DBMET01018 0.185 0.032 DBMET01437 0.171 0.046 DBMET00507 | DBMET01437 | |
| 0.14 | 0.05 | 0.162 | Acetylcholine muscarinic antagonist | 0.138 0.052 DBMET00733 0.162 0.037 DBMET00540 0.102 0.089 DBMET02222 0.159 0.039 DBMET01018 0.102 0.089 DBMET01437 | DBMET00540 | |
| 0.094 | 0.005 | 0.156 | Dopamine D5 agonist | 0.156 0.003 DBMET00733 0.052 0.016 DBMET00540 0.086 0.005 DBMET02222 0.076 0.007 DBMET01018 0.072 0.008 DBMET01437 0.044 0.023 DBMET00507 | DBMET00733 | |
| 0.166 | 0.077 | 0.186 | Antipruritic | 0.161 0.083 DBMET00733 0.186 0.059 DBMET01437 | DBMET01437 | |
| 0.122 | 0.033 | 0.367 | Alcohol dehydrogenase inhibitor | 0.187 0.014 DBMET00733 0.096 0.056 DBMET00540 0.142 0.023 DBMET02222 0.122 0.033 DBMET01018 0.367 0.004 DBMET01437 0.209 0.011 DBMET00507 | DBMET01437 | |
| 0.102 | 0.013 | 0.138 | Opioid agonist | 0.138 0.008 DBMET00733 0.056 0.034 DBMET01018 | DBMET00733 | |
| 0.111 | 0.025 | 0.368 | Keratolytic | 0.196 0.009 DBMET00733 0.1 0.03 DBMET00540 0.111 0.025 DBMET02222 0.144 0.015 DBMET01018 0.368 0.003 DBMET01437 0.127 0.019 DBMET00507 | DBMET01437 | |
| 0.104 | 0.02 | 0.169 | Estrogen-related receptor beta agonist | 0.136 0.005 DBMET00733 0.086 0.05 DBMET00540 0.13 0.007 DBMET02222 0.104 0.02 DBMET01018 0.124 0.009 DBMET01437 0.169 0.003 DBMET00507 | DBMET00507 | |
| 0.119 | 0.036 | 0.157 | Calcium antagonist | 0.095 0.051 DBMET00540 0.157 0.021 DBMET02222 0.13 0.03 DBMET01437 | DBMET02222 | |
| 0.136 | 0.053 | 0.283 | Monophenol monooxygenase inhibitor | 0.278 0.02 DBMET00733 0.141 0.05 DBMET00540 0.283 0.02 DBMET02222 0.247 0.024 DBMET01018 0.252 0.024 DBMET01437 0.139 0.052 DBMET00507 | DBMET02222 | |
| 0.108 | 0.025 | 0.108 | Nicotinic alpha4beta2 receptor antagonist | 0.069 0.064 DBMET00733 0.086 0.044 DBMET00540 0.08 0.05 DBMET02222 0.083 0.047 DBMET01437 | ||
| 0.111 | 0.028 | 0.186 | Glutathione S-transferase inhibitor | 0.116 0.025 DBMET00733 0.105 0.033 DBMET00540 0.101 0.036 DBMET02222 0.106 0.032 DBMET01018 0.145 0.013 DBMET01437 0.186 0.007 DBMET00507 | DBMET00507 | |
| 0.095 | 0.013 | 0.095 | Bombesin 3 receptor antagonist | 0.071 0.024 DBMET00733 | ||
| 0.149 | 0.067 | 0.27 | Cell wall synthesis inhibitor | 0.164 0.053 DBMET00733 0.248 0.016 DBMET00540 0.251 0.016 DBMET01018 0.27 0.013 DBMET01437 0.191 0.034 DBMET00507 | DBMET01437 | |
| 0.095 | 0.013 | 0.095 | Kallikrein 1 inhibitor | 0.07 0.024 DBMET00733 0.059 0.035 DBMET00540 0.059 0.035 DBMET02222 0.055 0.042 DBMET01018 | ||
| 0.085 | 0.003 | 0.085 | Histamine H1 receptor agonist | 0.054 0.013 DBMET00733 0.046 0.024 DBMET00540 0.052 0.016 DBMET02222 0.042 0.034 DBMET01437 | ||
| 0.13 | 0.048 | 0.227 | TRPA1 agonist | 0.145 0.035 DBMET00733 0.225 0.007 DBMET02222 0.109 0.073 DBMET01018 0.227 0.007 DBMET01437 0.153 0.029 DBMET00507 | DBMET01437 | |
| 0.096 | 0.014 | 0.185 | NMDA 2A receptor antagonist | 0.138 0.008 DBMET00733 0.154 0.007 DBMET00540 0.185 0.005 DBMET01018 0.1 0.013 DBMET01437 0.102 0.013 DBMET00507 | DBMET01018 | |
| 0.086 | 0.005 | 0.09 | Sphingosine kinase 1 inhibitor | 0.09 0.004 DBMET00733 0.06 0.009 DBMET00540 0.046 0.021 DBMET02222 0.056 0.011 DBMET01018 | DBMET00733 | |
| 0.088 | 0.006 | 0.176 | Glutamate (mGluR group III) antagonist | 0.066 0.01 DBMET00733 0.055 0.016 DBMET00540 0.041 0.037 DBMET02222 0.042 0.035 DBMET01018 0.176 0.003 DBMET01437 0.045 0.027 DBMET00507 | DBMET01437 | |
| 0.091 | 0.011 | 0.097 | Sphingosine 1-phosphate receptor 3 antagonist | 0.09 0.011 DBMET00733 0.079 0.018 DBMET00540 0.086 0.013 DBMET02222 0.076 0.02 DBMET01018 0.097 0.009 DBMET01437 0.083 0.015 DBMET00507 | DBMET01437 | |
| 0.11 | 0.03 | 0.11 | Factor XII inhibitor | 0.096 0.042 DBMET00733 | ||
| 0.097 | 0.017 | 0.155 | NMDA 2C receptor antagonist | 0.119 0.011 DBMET00733 0.135 0.008 DBMET00540 0.155 0.006 DBMET01018 0.12 0.01 DBMET01437 0.088 0.021 DBMET00507 | DBMET01018 | |
| 0.1 | 0.022 | 0.1 | Sirtuin 1 inhibitor | 0.099 0.023 DBMET00733 0.073 0.041 DBMET00540 0.076 0.039 DBMET01018 0.062 0.056 DBMET00507 | ||
| 0.143 | 0.066 | 0.245 | Neurotrophic factor | 0.139 0.069 DBMET00733 0.137 0.072 DBMET00540 0.245 0.013 DBMET02222 0.132 0.078 DBMET01018 0.17 0.044 DBMET01437 | DBMET02222 | |
| 0.088 | 0.011 | 0.088 | Histamine agonist | |||
| 0.144 | 0.067 | 0.316 | Amylase inhibitor | 0.241 0.031 DBMET00733 0.22 0.038 DBMET00540 0.149 0.064 DBMET02222 0.28 0.021 DBMET01018 0.316 0.016 DBMET01437 0.194 0.046 DBMET00507 | DBMET01437 | |
| 0.115 | 0.039 | 0.177 | Interleukin 1 beta converting enzyme inhibitor | 0.117 0.038 DBMET00733 0.135 0.024 DBMET02222 0.126 0.03 DBMET01437 0.177 0.009 DBMET00507 | DBMET00507 | |
| 0.082 | 0.006 | 0.107 | AMPA 4 receptor antagonist | 0.081 0.006 DBMET00733 0.044 0.021 DBMET00540 0.038 0.03 DBMET01018 0.107 0.005 DBMET01437 0.04 0.027 DBMET00507 | DBMET01437 | |
| 0.091 | 0.015 | 0.091 | Bombesin 2 receptor antagonist | 0.084 0.016 DBMET00733 0.052 0.031 DBMET00540 0.049 0.035 DBMET01018 0.055 0.027 DBMET01437 0.065 0.022 DBMET00507 | ||
| 0.081 | 0.005 | 0.15 | Diamine oxidase inhibitor | 0.051 0.014 DBMET00733 0.15 0.003 DBMET00540 0.061 0.009 DBMET02222 0.101 0.004 DBMET01018 0.053 0.013 DBMET01437 | DBMET00540 | |
| 0.108 | 0.032 | 0.175 | Glutamate receptor agonist | 0.077 0.056 DBMET00540 0.175 0.013 DBMET01437 | DBMET01437 | |
| 0.08 | 0.005 | 0.08 | Endothelial nitric-oxide synthase inhibitor | 0.035 0.017 DBMET00733 0.037 0.015 DBMET00540 | ||
| 0.094 | 0.019 | 0.163 | Phospholipase D inhibitor | 0.072 0.048 DBMET00733 0.085 0.028 DBMET00540 0.079 0.036 DBMET02222 0.065 0.064 DBMET01018 0.119 0.007 DBMET01437 0.163 0.002 DBMET00507 | DBMET00507 | |
| 0.119 | 0.045 | 0.119 | Falcipain inhibitor | 0.1 0.054 DBMET00733 0.088 0.064 DBMET02222 | ||
| 0.081 | 0.006 | 0.1 | Kainate receptor 2 antagonist | 0.057 0.013 DBMET00733 0.1 0.005 DBMET01437 0.037 0.024 DBMET00507 | DBMET01437 | |
| 0.093 | 0.019 | 0.093 | Human rhinovirus A protease inhibitor | 0.066 0.031 DBMET00733 0.085 0.022 DBMET02222 | ||
| 0.097 | 0.023 | 0.097 | Glucagon-like peptide 1 agonist | 0.093 0.026 DBMET00733 0.066 0.044 DBMET00540 0.067 0.044 DBMET01018 0.076 0.037 DBMET00507 | ||
| 0.077 | 0.005 | 0.077 | Dipeptidyl peptidase II inhibitor | 0.039 0.015 DBMET00733 0.031 0.024 DBMET01437 | ||
| 0.127 | 0.055 | 0.127 | Calcium channel N-type blocker | 0.102 0.091 DBMET01437 | ||
| 0.093 | 0.02 | 0.116 | MAP kinase kinase 7 inhibitor | 0.116 0.005 DBMET00733 0.086 0.031 DBMET00540 0.079 0.049 DBMET02222 0.103 0.01 DBMET01018 0.111 0.006 DBMET01437 0.09 0.024 DBMET00507 | DBMET00733 | |
| 0.1 | 0.028 | 0.21 | Alpha adrenoreceptor agonist | 0.087 0.034 DBMET00733 0.209 0.008 DBMET00540 0.21 0.008 DBMET01018 | DBMET01018 | |
| 0.091 | 0.02 | 0.21 | Purinergic P2X1 antagonist | 0.109 0.014 DBMET00733 0.097 0.018 DBMET00540 0.106 0.015 DBMET02222 0.102 0.016 DBMET01018 0.21 0.003 DBMET01437 0.087 0.021 DBMET00507 | DBMET01437 | |
| 0.093 | 0.022 | 0.163 | GABA B receptor agonist | 0.115 0.009 DBMET00733 0.11 0.011 DBMET00540 0.096 0.019 DBMET02222 0.125 0.006 DBMET01018 0.163 0.004 DBMET01437 0.111 0.01 DBMET00507 | DBMET01437 | |
| 0.224 | 0.153 | 0.378 | Apoptosis antagonist | 0.298 0.087 DBMET00733 0.206 0.172 DBMET00540 0.378 0.045 DBMET02222 0.261 0.117 DBMET01018 0.342 0.06 DBMET01437 0.337 0.062 DBMET00507 | DBMET02222 | |
| 0.075 | 0.004 | 0.12 | Glutamate (mGluR8) agonist | 0.071 0.005 DBMET00733 0.071 0.005 DBMET00540 0.046 0.015 DBMET02222 0.06 0.007 DBMET01018 0.12 0.002 DBMET01437 0.05 0.012 DBMET00507 | DBMET01437 | |
| 0.074 | 0.003 | 0.094 | Tryptophan 5 hydroxylase inhibitor | 0.057 0.004 DBMET00733 0.066 0.004 DBMET00540 0.045 0.008 DBMET02222 0.049 0.005 DBMET01018 0.057 0.004 DBMET01437 0.094 0.002 DBMET00507 | DBMET00507 | |
| 0.079 | 0.009 | 0.127 | Beta 2 adrenoreceptor agonist | 0.101 0.004 DBMET00733 0.098 0.004 DBMET00540 0.059 0.054 DBMET02222 0.127 0.003 DBMET01018 0.067 0.026 DBMET01437 0.069 0.02 DBMET00507 | DBMET01018 | |
| 0.091 | 0.021 | 0.116 | Ribonucleoside-diphosphate reductase inhibitor | 0.116 0.016 DBMET00733 0.061 0.034 DBMET00540 0.049 0.042 DBMET02222 0.071 0.029 DBMET01018 0.05 0.04 DBMET01437 0.081 0.024 DBMET00507 | DBMET00733 | |
| 0.074 | 0.004 | 0.109 | Glutamate (mGluR1a) agonist | 0.042 0.005 DBMET00733 0.037 0.006 DBMET00540 0.026 0.011 DBMET02222 0.024 0.013 DBMET01018 0.109 0.004 DBMET01437 0.061 0.004 DBMET00507 | DBMET01437 | |
| 0.077 | 0.008 | 0.077 | Dipeptidyl peptidase IV inhibitor | 0.044 0.031 DBMET00733 | ||
| 0.089 | 0.02 | 0.089 | Glutamate (mGluR1) antagonist | 0.05 0.048 DBMET00733 0.082 0.023 DBMET01437 0.05 0.048 DBMET00507 | ||
| 0.121 | 0.052 | 0.203 | Protein kinase C gamma inhibitor | 0.128 0.046 DBMET00733 0.154 0.029 DBMET00540 0.161 0.026 DBMET01018 0.203 0.013 DBMET01437 0.095 0.087 DBMET00507 | DBMET01437 | |
| 0.113 | 0.045 | 0.113 | Falcipain 2 inhibitor | 0.096 0.054 DBMET00733 0.084 0.065 DBMET02222 | ||
| 0.092 | 0.024 | 0.092 | Vanilloid 4 agonist | 0.071 0.062 DBMET00733 0.079 0.042 DBMET00540 0.089 0.028 DBMET02222 0.091 0.025 DBMET01437 0.092 0.024 DBMET00507 | ||
| 0.091 | 0.023 | 0.114 | Ribonucleotide reductase inhibitor | 0.114 0.018 DBMET00733 0.062 0.035 DBMET00540 0.048 0.044 DBMET02222 0.072 0.03 DBMET01018 0.051 0.042 DBMET01437 0.084 0.025 DBMET00507 | DBMET00733 | |
| 0.08 | 0.012 | 0.091 | Epithelial sodium channel blocker | 0.075 0.015 DBMET00733 0.051 0.045 DBMET00540 0.055 0.037 DBMET02222 0.051 0.046 DBMET01018 0.061 0.028 DBMET01437 0.091 0.009 DBMET00507 | DBMET00507 | |
| 0.157 | 0.089 | 0.222 | ATPase inhibitor | 0.162 0.082 DBMET00733 0.144 0.112 DBMET00540 0.166 0.076 DBMET02222 0.146 0.109 DBMET01018 0.222 0.023 DBMET01437 0.2 0.037 DBMET00507 | DBMET01437 | |
| 0.1 | 0.032 | 0.146 | Glycine receptor antagonist | 0.079 0.058 DBMET00733 0.072 0.071 DBMET00540 0.106 0.028 DBMET02222 0.146 0.008 DBMET01437 0.118 0.019 DBMET00507 | DBMET01437 | |
| 0.074 | 0.006 | 0.074 | Growth hormone releasing factor agonist | |||
| 0.077 | 0.01 | 0.156 | Kainate receptor antagonist | 0.068 0.013 DBMET00733 0.156 0.004 DBMET01437 0.044 0.025 DBMET00507 | DBMET01437 | |
| 0.083 | 0.016 | 0.083 | Histone deacetylase SIRT3 inhibitor | 0.073 0.024 DBMET00733 0.061 0.045 DBMET02222 0.074 0.023 DBMET00507 | ||
| 0.074 | 0.008 | 0.074 | GHS receptor agonist | 0.05 0.02 DBMET00733 | ||
| 0.088 | 0.022 | 0.088 | Dopamine uptake inhibitor | 0.062 0.036 DBMET00733 0.067 0.032 DBMET00540 0.054 0.044 DBMET01018 | ||
| 0.085 | 0.02 | 0.251 | Acyl-CoA dehydrogenase inhibitor | 0.065 0.03 DBMET00733 0.093 0.018 DBMET00540 0.115 0.013 DBMET02222 0.064 0.03 DBMET01018 0.251 0.003 DBMET01437 0.14 0.01 DBMET00507 | DBMET01437 | |
| 0.078 | 0.013 | 0.078 | Nicotinic alpha3beta2 receptor antagonist | 0.054 0.036 DBMET00733 0.067 0.02 DBMET02222 0.066 0.021 DBMET01437 | ||
| 0.13 | 0.065 | 0.143 | Cholinergic antagonist | 0.121 0.073 DBMET00733 0.143 0.057 DBMET00540 0.136 0.061 DBMET01018 | DBMET00540 | |
| 0.076 | 0.011 | 0.107 | Lysophosphatidic acid 3 receptor antagonist | 0.066 0.017 DBMET00733 0.071 0.014 DBMET00540 0.069 0.015 DBMET02222 0.058 0.025 DBMET01018 0.107 0.004 DBMET01437 0.066 0.018 DBMET00507 | DBMET01437 | |
| 0.127 | 0.064 | 0.138 | Acetylcholine antagonist | 0.118 0.072 DBMET00733 0.138 0.057 DBMET00540 0.133 0.06 DBMET01018 | DBMET00540 | |
| 0.08 | 0.017 | 0.08 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.098 | 0.036 | 0.164 | Opioid kappa receptor antagonist | 0.164 0.014 DBMET00733 0.085 0.051 DBMET01018 | DBMET00733 | |
| 0.077 | 0.015 | 0.639 | Aconitate hydratase inhibitor | 0.06 0.026 DBMET00733 0.09 0.01 DBMET00540 0.124 0.005 DBMET02222 0.059 0.027 DBMET01018 0.639 0.001 DBMET01437 0.179 0.004 DBMET00507 | DBMET01437 | |
| 0.155 | 0.093 | 0.155 | LIM domain kinase 1 inhibitor | 0.128 0.124 DBMET00733 0.139 0.11 DBMET01437 | ||
| 0.07 | 0.008 | 0.24 | Fumarate hydratase inhibitor | 0.06 0.01 DBMET00733 0.072 0.008 DBMET00540 0.1 0.005 DBMET02222 0.051 0.013 DBMET01018 0.24 0.003 DBMET01437 0.062 0.01 DBMET00507 | DBMET01437 | |
| 0.103 | 0.042 | 0.151 | Bile acid receptor antagonist | 0.116 0.023 DBMET00733 0.095 0.062 DBMET00540 0.114 0.026 DBMET02222 0.103 0.042 DBMET01018 0.151 0.007 DBMET01437 0.119 0.021 DBMET00507 | DBMET01437 | |
| 0.093 | 0.032 | 0.101 | CC chemokine 5 receptor agonist | 0.101 0.021 DBMET00733 0.099 0.022 DBMET02222 0.086 0.046 DBMET01437 | DBMET00733 | |
| 0.092 | 0.031 | 0.092 | Thrombin inhibitor | 0.069 0.056 DBMET00733 0.077 0.046 DBMET00507 | ||
| 0.119 | 0.059 | 0.155 | Alpha 2b adrenoreceptor antagonist | 0.092 0.083 DBMET00733 0.155 0.037 DBMET00540 0.144 0.041 DBMET01018 | DBMET00540 | |
| 0.119 | 0.059 | 0.119 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.085 | 0.025 | 0.159 | NMDA receptor glycine site agonist | 0.065 0.041 DBMET00733 0.069 0.037 DBMET00540 0.061 0.045 DBMET02222 0.159 0.004 DBMET01437 0.129 0.007 DBMET00507 | DBMET01437 | |
| 0.083 | 0.024 | 0.083 | Plasminogen activator inhibitor | 0.074 0.029 DBMET00733 0.054 0.044 DBMET00540 0.062 0.038 DBMET00507 | ||
| 0.126 | 0.067 | 0.126 | Nav1.3 sodium channel blocker | 0.102 0.095 DBMET00540 0.122 0.072 DBMET01437 0.119 0.075 DBMET00507 | ||
| 0.081 | 0.022 | 0.081 | Cathepsin E inhibitor | 0.068 0.031 DBMET00733 0.072 0.028 DBMET00540 0.063 0.037 DBMET01018 | ||
| 0.207 | 0.148 | 0.207 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.104 | 0.046 | 0.127 | Protein kinase C zeta inhibitor | 0.127 0.028 DBMET00733 0.099 0.052 DBMET01437 | DBMET00733 | |
| 0.195 | 0.137 | 0.195 | MAP kinase kinase 3 inhibitor | 0.185 0.173 DBMET00540 | ||
| 0.08 | 0.023 | 0.173 | Beta 3 adrenoreceptor antagonist | 0.118 0.01 DBMET00733 0.138 0.007 DBMET00540 0.063 0.048 DBMET02222 0.173 0.005 DBMET01018 0.075 0.027 DBMET01437 0.064 0.046 DBMET00507 | DBMET01018 | |
| 0.066 | 0.008 | 0.095 | Opioid delta receptor agonist | 0.095 0.005 DBMET00733 0.039 0.02 DBMET01018 | DBMET00733 | |
| 0.108 | 0.052 | 0.201 | Folate antagonist | 0.098 0.069 DBMET00733 0.119 0.04 DBMET01437 0.201 0.01 DBMET00507 | DBMET00507 | |
| 0.065 | 0.009 | 0.078 | Arginase inhibitor | 0.07 0.008 DBMET00733 0.053 0.013 DBMET00540 0.05 0.015 DBMET01018 0.078 0.006 DBMET01437 0.059 0.011 DBMET00507 | DBMET01437 | |
| 0.071 | 0.015 | 0.071 | Prolyl endopeptidase inhibitor | 0.056 0.028 DBMET00733 0.066 0.019 DBMET02222 0.066 0.018 DBMET01437 0.069 0.016 DBMET00507 | ||
| 0.122 | 0.066 | 0.169 | Alkylator | 0.138 0.053 DBMET00733 0.142 0.051 DBMET00540 0.154 0.045 DBMET01018 0.145 0.049 DBMET01437 0.169 0.037 DBMET00507 | DBMET00507 | |
| 0.065 | 0.01 | 0.076 | Geranyltranstransferase inhibitor | 0.06 0.014 DBMET00733 0.046 0.027 DBMET00540 0.056 0.017 DBMET02222 0.076 0.005 DBMET01437 0.056 0.017 DBMET00507 | DBMET01437 | |
| 0.096 | 0.041 | 0.105 | Myeloperoxidase inhibitor | 0.105 0.03 DBMET00733 0.081 0.064 DBMET02222 0.077 0.072 DBMET01018 0.105 0.029 DBMET01437 | DBMET01437 | |
| 0.091 | 0.037 | 0.104 | Interferon agonist | 0.081 0.051 DBMET00733 0.1 0.029 DBMET00540 0.083 0.047 DBMET02222 0.083 0.048 DBMET01018 0.104 0.025 DBMET01437 0.074 0.063 DBMET00507 | DBMET01437 | |
| 0.07 | 0.016 | 0.111 | Alpha-mannosidase inhibitor | 0.07 0.017 DBMET00733 0.107 0.005 DBMET00540 0.057 0.031 DBMET02222 0.093 0.008 DBMET01018 0.095 0.007 DBMET01437 0.111 0.005 DBMET00507 | DBMET00507 | |
| 0.08 | 0.026 | 0.104 | Exportin-1 inhibitor | 0.082 0.022 DBMET00540 0.104 0.008 DBMET02222 0.067 0.051 DBMET01018 0.091 0.014 DBMET01437 0.069 0.045 DBMET00507 | DBMET02222 | |
| 0.132 | 0.078 | 0.157 | Cytokine production inhibitor | 0.157 0.057 DBMET02222 0.116 0.094 DBMET01437 | DBMET02222 | |
| 0.069 | 0.016 | 0.146 | NMDA receptor subunit 3B antagonist | 0.143 0.007 DBMET00733 0.065 0.017 DBMET00540 0.099 0.011 DBMET01018 0.146 0.006 DBMET01437 0.052 0.024 DBMET00507 | DBMET01437 | |
| 0.063 | 0.01 | 0.069 | VLA-4 antagonist | 0.049 0.013 DBMET00733 0.069 0.009 DBMET00507 | DBMET00507 | |
| 0.071 | 0.017 | 0.071 | Complement C3a chemotactic receptor antagonist | 0.052 0.026 DBMET00733 0.049 0.027 DBMET00540 0.051 0.026 DBMET00507 | ||
| 0.068 | 0.015 | 0.12 | NMDA receptor subunit 3A antagonist | 0.119 0.007 DBMET00733 0.085 0.01 DBMET00540 0.117 0.007 DBMET01018 0.12 0.007 DBMET01437 0.049 0.02 DBMET00507 | DBMET01437 | |
| 0.115 | 0.063 | 0.128 | Sphingosine 1-phosphate receptor 2 agonist | 0.109 0.078 DBMET00733 0.128 0.044 DBMET00507 | DBMET00507 | |
| 0.065 | 0.013 | 0.068 | Somatostatin 1 antagonist | 0.06 0.015 DBMET00733 0.068 0.012 DBMET00540 0.066 0.013 DBMET01018 | DBMET00540 | |
| 0.078 | 0.026 | 0.078 | Cathepsin L inhibitor | 0.061 0.037 DBMET00733 0.065 0.034 DBMET02222 0.055 0.044 DBMET00507 | ||
| 0.06 | 0.008 | 0.189 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.073 0.004 DBMET00733 0.058 0.008 DBMET00540 0.057 0.009 DBMET02222 0.064 0.006 DBMET01018 0.189 0.001 DBMET01437 0.048 0.018 DBMET00507 | DBMET01437 | |
| 0.078 | 0.026 | 0.078 | Cathepsin D inhibitor | 0.052 0.04 DBMET00733 | ||
| 0.063 | 0.011 | 0.063 | Cytokine production stimulant | 0.05 0.029 DBMET00733 0.062 0.011 DBMET00540 0.06 0.012 DBMET02222 0.051 0.026 DBMET01018 0.047 0.038 DBMET01437 | ||
| 0.107 | 0.056 | 0.437 | Bronchodilator | 0.141 0.034 DBMET00733 0.437 0.005 DBMET00540 0.419 0.005 DBMET01018 | DBMET00540 | |
| 0.241 | 0.19 | 0.241 | Analgesic | 0.223 0.211 DBMET00733 | ||
| 0.103 | 0.053 | 0.405 | Electrolyte absorption antagonist | 0.095 0.065 DBMET00540 0.123 0.034 DBMET02222 0.405 0.003 DBMET01437 0.223 0.006 DBMET00507 | DBMET01437 | |
| 0.064 | 0.014 | 0.07 | Oxytocin agonist | 0.07 0.01 DBMET00733 0.047 0.025 DBMET00540 0.046 0.026 DBMET02222 0.059 0.017 DBMET01018 0.042 0.03 DBMET01437 0.039 0.033 DBMET00507 | DBMET00733 | |
| 0.073 | 0.023 | 0.076 | Botulinum neurotoxin type A inhibitor | 0.076 0.02 DBMET00733 0.063 0.034 DBMET00540 0.061 0.035 DBMET01018 0.061 0.036 DBMET01437 0.073 0.022 DBMET00507 | DBMET00733 | |
| 0.132 | 0.082 | 0.24 | Protein kinase stimulant | 0.179 0.05 DBMET00733 0.171 0.055 DBMET00540 0.14 0.076 DBMET02222 0.208 0.039 DBMET01018 0.24 0.029 DBMET01437 0.128 0.085 DBMET00507 | DBMET01437 | |
| 0.065 | 0.015 | 0.065 | Cathepsin L2 inhibitor | 0.052 0.021 DBMET00733 0.046 0.025 DBMET02222 | ||
| 0.054 | 0.004 | 0.054 | Aminopeptidase P inhibitor | 0.036 0.007 DBMET00733 0.034 0.007 DBMET00540 0.024 0.015 DBMET01018 | ||
| 0.067 | 0.018 | 0.067 | Glutamate (mGluR group I) agonist | 0.06 0.022 DBMET01437 | ||
| 0.093 | 0.044 | 0.28 | Carbonic anhydrase VI inhibitor | 0.15 0.021 DBMET00733 0.105 0.036 DBMET02222 0.096 0.042 DBMET01018 0.28 0.007 DBMET01437 0.116 0.031 DBMET00507 | DBMET01437 | |
| 0.054 | 0.005 | 0.055 | Methionyl aminopeptidase 1 inhibitor | 0.039 0.013 DBMET00733 0.055 0.005 DBMET00540 0.03 0.026 DBMET02222 0.04 0.012 DBMET01018 0.05 0.006 DBMET01437 0.029 0.028 DBMET00507 | DBMET00540 | |
| 0.08 | 0.032 | 0.082 | Neutrophil collagenase inhibitor | 0.078 0.033 DBMET00733 0.063 0.047 DBMET01437 0.082 0.03 DBMET00507 | DBMET00507 | |
| 0.082 | 0.033 | 0.082 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.072 | 0.024 | 0.072 | Urokinase inhibitor | 0.055 0.03 DBMET00733 0.056 0.03 DBMET00540 0.046 0.034 DBMET01018 | ||
| 0.053 | 0.005 | 0.053 | Growth hormone release promoting | |||
| 0.058 | 0.01 | 0.058 | Sirtuin 2 inhibitor | 0.045 0.015 DBMET00733 0.038 0.019 DBMET02222 0.033 0.023 DBMET00507 | ||
| 0.107 | 0.059 | 0.152 | Urease inhibitor | 0.123 0.042 DBMET00733 0.139 0.029 DBMET00540 0.129 0.037 DBMET02222 0.151 0.022 DBMET01018 0.152 0.022 DBMET01437 0.142 0.027 DBMET00507 | DBMET01437 | |
| 0.057 | 0.009 | 0.057 | Phenylethanolamine N methyltransferase inhibitor | 0.049 0.015 DBMET00733 | ||
| 0.066 | 0.019 | 0.071 | Toll-Like receptor 2 agonist | 0.055 0.021 DBMET00733 0.062 0.019 DBMET00540 0.048 0.025 DBMET01018 0.037 0.032 DBMET01437 0.071 0.018 DBMET00507 | DBMET00507 | |
| 0.059 | 0.012 | 0.059 | Somatostatin 2 antagonist | 0.047 0.016 DBMET00733 0.036 0.019 DBMET00540 0.029 0.02 DBMET01018 | ||
| 0.064 | 0.017 | 0.064 | Nicotinic receptor alpha3 subunit antagonist | 0.046 0.028 DBMET00733 0.044 0.03 DBMET02222 | ||
| 0.091 | 0.044 | 0.11 | 3C-Like protease (SARS coronavirus) inhibitor | 0.084 0.059 DBMET00733 0.083 0.061 DBMET02222 0.11 0.025 DBMET01437 | DBMET01437 | |
| 0.069 | 0.023 | 0.069 | Cyclin A1 inhibitor | 0.055 0.049 DBMET00540 0.054 0.053 DBMET00507 | ||
| 0.068 | 0.022 | 0.07 | Angiotensin-converting enzyme inhibitor | 0.063 0.026 DBMET00733 0.058 0.032 DBMET01437 0.07 0.019 DBMET00507 | DBMET00507 | |
| 0.051 | 0.005 | 0.092 | Glutamate (mGluR3) agonist | 0.062 0.004 DBMET00733 0.044 0.007 DBMET00540 0.032 0.023 DBMET02222 0.047 0.005 DBMET01018 0.092 0.002 DBMET01437 0.043 0.008 DBMET00507 | DBMET01437 | |
| 0.071 | 0.025 | 0.143 | Beta 1 adrenoreceptor antagonist | 0.089 0.013 DBMET00733 0.121 0.007 DBMET00540 0.059 0.037 DBMET02222 0.143 0.005 DBMET01018 0.06 0.035 DBMET01437 0.067 0.029 DBMET00507 | DBMET01018 | |
| 0.171 | 0.125 | 0.373 | Platelet antagonist | 0.169 0.127 DBMET00733 0.154 0.14 DBMET00540 0.303 0.052 DBMET01437 0.373 0.033 DBMET00507 | DBMET00507 | |
| 0.076 | 0.03 | 0.17 | Beta adrenoreceptor antagonist | 0.107 0.014 DBMET00733 0.138 0.007 DBMET00540 0.062 0.052 DBMET02222 0.17 0.005 DBMET01018 0.07 0.039 DBMET01437 0.081 0.026 DBMET00507 | DBMET01018 | |
| 0.075 | 0.029 | 0.085 | Interferon inducer | 0.065 0.043 DBMET00733 0.082 0.023 DBMET00540 0.064 0.044 DBMET02222 0.067 0.04 DBMET01018 0.085 0.02 DBMET01437 0.06 0.053 DBMET00507 | DBMET01437 | |
| 0.063 | 0.017 | 0.13 | Glutamate (mGluR group III) agonist | 0.044 0.029 DBMET00733 0.074 0.014 DBMET00540 0.046 0.027 DBMET01018 0.13 0.006 DBMET01437 0.044 0.029 DBMET00507 | DBMET01437 | |
| 0.15 | 0.104 | 0.325 | DNA methyltransferase I inhibitor | 0.194 0.072 DBMET00733 0.164 0.091 DBMET02222 0.325 0.019 DBMET01437 0.268 0.039 DBMET00507 | DBMET01437 | |
| 0.055 | 0.01 | 0.055 | Baculoviral IAP repeat-containing protein inhibitor | 0.047 0.028 DBMET00733 0.046 0.032 DBMET00540 | ||
| 0.091 | 0.047 | 0.131 | Hematopoietic | 0.089 0.052 DBMET00733 0.08 0.073 DBMET00540 0.105 0.031 DBMET01437 0.131 0.018 DBMET00507 | DBMET00507 | |
| 0.061 | 0.016 | 0.11 | Mannosidase inhibitor | 0.06 0.017 DBMET00733 0.105 0.005 DBMET00540 0.046 0.031 DBMET02222 0.087 0.007 DBMET01018 0.11 0.005 DBMET01437 0.1 0.006 DBMET00507 | DBMET01437 | |
| 0.053 | 0.008 | 0.053 | Thrombin receptor antagonist | 0.03 0.017 DBMET00733 0.03 0.017 DBMET00540 | ||
| 0.061 | 0.017 | 0.061 | Bombesin antagonist | 0.052 0.026 DBMET00733 | ||
| 0.058 | 0.014 | 0.058 | Neurokinin 2 agonist | 0.04 0.031 DBMET00733 | ||
| 0.052 | 0.008 | 0.061 | AMPA receptor agonist | 0.041 0.016 DBMET00733 0.035 0.025 DBMET00540 0.061 0.005 DBMET02222 0.033 0.029 DBMET01437 | DBMET02222 | |
| 0.052 | 0.008 | 0.075 | Glutamate (mGluR8) antagonist | 0.046 0.011 DBMET00733 0.048 0.01 DBMET00540 0.041 0.016 DBMET01018 0.075 0.004 DBMET01437 0.038 0.021 DBMET00507 | DBMET01437 | |
| 0.074 | 0.03 | 0.074 | Trypsin inhibitor | 0.061 0.045 DBMET00733 0.058 0.052 DBMET01437 0.067 0.036 DBMET00507 | ||
| 0.052 | 0.008 | 0.062 | AMPA 3 receptor antagonist | 0.046 0.01 DBMET00733 0.062 0.005 DBMET01437 0.05 0.009 DBMET00507 | DBMET01437 | |
| 0.2 | 0.157 | 0.2 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.184 0.177 DBMET00733 | ||
| 0.059 | 0.017 | 0.059 | Melanocortin 1 antagonist | 0.041 0.024 DBMET00733 | ||
| 0.063 | 0.021 | 0.15 | Beta 2 adrenoreceptor antagonist | 0.087 0.01 DBMET00733 0.118 0.006 DBMET00540 0.15 0.004 DBMET01018 0.05 0.036 DBMET01437 0.064 0.021 DBMET00507 | DBMET01018 | |
| 0.056 | 0.014 | 0.056 | Plasmepsin II inhibitor | 0.047 0.02 DBMET00733 | ||
| 0.059 | 0.017 | 0.076 | Dopamine beta hydroxylase inhibitor | 0.068 0.009 DBMET00733 0.058 0.018 DBMET02222 0.05 0.031 DBMET01018 0.076 0.006 DBMET01437 | DBMET01437 | |
| 0.061 | 0.02 | 0.085 | Adenosine deaminase inhibitor | 0.06 0.021 DBMET00733 0.053 0.027 DBMET00540 0.046 0.034 DBMET02222 0.043 0.037 DBMET01018 0.085 0.008 DBMET01437 0.061 0.019 DBMET00507 | DBMET01437 | |
| 0.142 | 0.101 | 0.165 | Interleukin 6 antagonist | 0.165 0.07 DBMET00733 0.136 0.113 DBMET01018 0.131 0.123 DBMET00507 | DBMET00733 | |
| 0.112 | 0.072 | 0.171 | Caspase 3 inhibitor | 0.114 0.069 DBMET00733 0.102 0.089 DBMET00540 0.125 0.052 DBMET02222 0.163 0.02 DBMET01437 0.171 0.017 DBMET00507 | DBMET00507 | |
| 0.051 | 0.012 | 0.051 | Somatostatin 5 agonist | 0.04 0.019 DBMET00733 0.038 0.021 DBMET00540 0.033 0.026 DBMET01018 | ||
| 0.068 | 0.03 | 0.068 | Cathepsin B inhibitor | 0.05 0.048 DBMET00733 0.052 0.045 DBMET02222 | ||
| 0.052 | 0.014 | 0.16 | Beta adrenoreceptor agonist | 0.073 0.005 DBMET00733 0.102 0.004 DBMET00540 0.16 0.003 DBMET01018 0.052 0.015 DBMET01437 0.047 0.025 DBMET00507 | DBMET01018 | |
| 0.052 | 0.014 | 0.092 | Membrane dipeptidase inhibitor | 0.041 0.025 DBMET00733 0.065 0.008 DBMET00540 0.04 0.026 DBMET02222 0.046 0.019 DBMET01018 0.074 0.006 DBMET01437 0.092 0.004 DBMET00507 | DBMET00507 | |
| 0.065 | 0.026 | 0.065 | Plasmin inhibitor | 0.045 0.035 DBMET00733 | ||
| 0.166 | 0.128 | 0.422 | Cyclic AMP phosphodiesterase inhibitor | 0.173 0.119 DBMET00733 0.205 0.09 DBMET00540 0.422 0.014 DBMET02222 0.212 0.085 DBMET01018 0.343 0.027 DBMET01437 | DBMET02222 | |
| 0.12 | 0.082 | 0.149 | Papain-like protease (SARS coronavirus) inhibitor | 0.149 0.035 DBMET00733 0.117 0.089 DBMET02222 0.132 0.057 DBMET01018 0.127 0.066 DBMET00507 | DBMET00733 | |
| 0.056 | 0.018 | 0.056 | Growth hormone release inhibitor | 0.053 0.019 DBMET00733 0.05 0.022 DBMET00540 0.05 0.021 DBMET01018 | ||
| 0.158 | 0.12 | 0.226 | Anticonvulsant | 0.226 0.067 DBMET02222 0.153 0.126 DBMET01437 0.167 0.11 DBMET00507 | DBMET02222 | |
| 0.209 | 0.172 | 0.217 | Ca(v)3.3 blocker | 0.217 0.158 DBMET02222 | DBMET02222 | |
| 0.041 | 0.004 | 0.05 | Vanilloid 2 agonist | 0.043 0.004 DBMET00733 0.029 0.01 DBMET00540 0.038 0.004 DBMET02222 0.03 0.01 DBMET01018 0.05 0.003 DBMET01437 | DBMET01437 | |
| 0.053 | 0.016 | 0.059 | Calcitonin receptor agonist | 0.059 0.015 DBMET00733 0.042 0.019 DBMET00540 0.046 0.018 DBMET01018 0.029 0.028 DBMET01437 0.052 0.016 DBMET00507 | DBMET00733 | |
| 0.044 | 0.007 | 0.044 | Adenosine uptake inhibitor | 0.034 0.027 DBMET00733 0.044 0.007 DBMET02222 | ||
| 0.062 | 0.026 | 0.062 | Protease activated receptor 1 antagonist | |||
| 0.08 | 0.044 | 0.237 | NMDA 2 receptor antagonist | 0.138 0.019 DBMET00733 0.167 0.013 DBMET00540 0.237 0.007 DBMET01018 0.132 0.021 DBMET01437 0.071 0.05 DBMET00507 | DBMET01018 | |
| 0.084 | 0.048 | 0.161 | Cell adhesion molecule inhibitor | 0.117 0.025 DBMET01437 0.161 0.013 DBMET00507 | DBMET00507 | |
| 0.048 | 0.012 | 0.057 | Integrin alpha4 antagonist | 0.024 0.018 DBMET00733 0.057 0.01 DBMET00507 | DBMET00507 | |
| 0.054 | 0.018 | 0.054 | Cathepsin L1 inhibitor | 0.04 0.027 DBMET02222 | ||
| 0.054 | 0.018 | 0.128 | Leukotriene A4 hydrolase inhibitor | 0.04 0.025 DBMET00733 0.128 0.005 DBMET01437 | DBMET01437 | |
| 0.085 | 0.05 | 0.085 | Acetylcholine nicotinic antagonist | |||
| 0.068 | 0.034 | 0.163 | Alpha 2 adrenoreceptor agonist | 0.055 0.049 DBMET00733 0.163 0.005 DBMET00540 0.153 0.006 DBMET01018 | DBMET00540 | |
| 0.045 | 0.011 | 0.045 | Trypsin II inhibitor | 0.027 0.025 DBMET00733 0.028 0.023 DBMET00507 | ||
| 0.048 | 0.015 | 0.048 | Cathepsin F inhibitor | |||
| 0.056 | 0.023 | 0.056 | Melanocortin antagonist | |||
| 0.037 | 0.005 | 0.037 | Dipeptidyl peptidase IX inhibitor | 0.017 0.01 DBMET00733 | ||
| 0.076 | 0.044 | 0.088 | Potassium channel (Tandem pore domain) blocker | 0.077 0.043 DBMET02222 0.076 0.044 DBMET01437 0.088 0.02 DBMET00507 | DBMET00507 | |
| 0.155 | 0.123 | 0.163 | Focal adhesion kinase 2 inhibitor | 0.163 0.11 DBMET01437 | DBMET01437 | |
| 0.053 | 0.022 | 0.053 | Melanocortin 4 antagonist | |||
| 0.146 | 0.116 | 0.249 | Catenin beta inhibitor | 0.185 0.046 DBMET00733 0.249 0.011 DBMET01437 0.164 0.076 DBMET00507 | DBMET01437 | |
| 0.046 | 0.016 | 0.046 | Potassium channel Kv1.1 blocker | 0.042 0.02 DBMET02222 | ||
| 0.065 | 0.035 | 0.066 | Prolactin release inhibitor | 0.066 0.032 DBMET00733 | DBMET00733 | |
| 0.045 | 0.015 | 0.047 | VCAM-1 antagonist | 0.044 0.017 DBMET00733 0.047 0.011 DBMET00507 | DBMET00507 | |
| 0.044 | 0.015 | 0.047 | VCAM antagonist | 0.043 0.017 DBMET00733 0.047 0.011 DBMET00507 | DBMET00507 | |
| 0.09 | 0.061 | 0.09 | Polo-like kinase-1 inhibitor | 0.082 0.079 DBMET01437 | ||
| 0.093 | 0.064 | 0.133 | MAO B inhibitor | 0.133 0.044 DBMET00733 | DBMET00733 | |
| 0.055 | 0.025 | 0.07 | Neurotensin receptor antagonist | 0.07 0.02 DBMET00733 0.039 0.038 DBMET00507 | DBMET00733 | |
| 0.047 | 0.018 | 0.047 | Kinesin antagonist | 0.047 0.017 DBMET00733 | ||
| 0.047 | 0.018 | 0.047 | Kinesin-like protein 1 inhibitor | 0.047 0.017 DBMET00733 | ||
| 0.085 | 0.055 | 0.195 | D-Ala-D-Ala ligase inhibitor | 0.106 0.023 DBMET00733 0.087 0.051 DBMET00540 0.094 0.037 DBMET02222 0.101 0.028 DBMET01018 0.195 0.003 DBMET01437 0.111 0.019 DBMET00507 | DBMET01437 | |
| 0.037 | 0.008 | 0.037 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.036 0.009 DBMET00733 0.028 0.017 DBMET00540 0.028 0.017 DBMET01018 | ||
| 0.124 | 0.095 | 0.32 | Mannose-6-phosphate isomerase inhibitor | 0.118 0.105 DBMET00733 0.119 0.103 DBMET00540 0.154 0.061 DBMET02222 0.32 0.005 DBMET01437 0.179 0.043 DBMET00507 | DBMET01437 | |
| 0.081 | 0.052 | 0.114 | Metalloproteinase-2 inhibitor | 0.087 0.046 DBMET00733 0.07 0.066 DBMET01437 0.114 0.032 DBMET00507 | DBMET00507 | |
| 0.049 | 0.02 | 0.053 | Sphingosine 1-phosphate receptor 1 agonist | 0.045 0.026 DBMET00733 0.052 0.019 DBMET00540 0.042 0.03 DBMET01018 0.053 0.017 DBMET01437 0.05 0.02 DBMET00507 | DBMET01437 | |
| 0.032 | 0.003 | 0.032 | Tryptophan hydroxylase 1 inhibitor | 0.025 0.004 DBMET00733 0.027 0.004 DBMET00540 0.022 0.005 DBMET01018 0.024 0.004 DBMET00507 | ||
| 0.056 | 0.028 | 0.1 | Antimetabolite | 0.049 0.032 DBMET00733 0.042 0.039 DBMET00540 0.045 0.035 DBMET01437 0.1 0.016 DBMET00507 | DBMET00507 | |
| 0.037 | 0.008 | 0.097 | Kainate receptor 1 antagonist | 0.028 0.011 DBMET00733 0.097 0.004 DBMET01437 | DBMET01437 | |
| 0.034 | 0.005 | 0.034 | Aminopeptidase A inhibitor | 0.03 0.006 DBMET00733 0.02 0.011 DBMET00540 0.016 0.014 DBMET01018 0.03 0.006 DBMET01437 0.02 0.011 DBMET00507 | ||
| 0.037 | 0.009 | 0.037 | Motilin receptor antagonist | 0.033 0.011 DBMET00733 | ||
| 0.053 | 0.026 | 0.053 | Histamine H4 receptor antagonist | |||
| 0.071 | 0.044 | 0.071 | Neuronal nicotinic receptor antagonist | |||
| 0.059 | 0.032 | 0.059 | 5 Hydroxytryptamine 7 agonist | 0.055 0.042 DBMET00733 | ||
| 0.037 | 0.01 | 0.094 | Methionyl aminopeptidase 2 inhibitor | 0.022 0.021 DBMET00733 0.024 0.019 DBMET00540 0.094 0.004 DBMET01437 | DBMET01437 | |
| 0.031 | 0.004 | 0.049 | Neuraminidase (Influenza B) inhibitor | 0.032 0.004 DBMET00733 0.036 0.004 DBMET00540 0.022 0.012 DBMET02222 0.033 0.004 DBMET01018 0.049 0.002 DBMET01437 0.021 0.014 DBMET00507 | DBMET01437 | |
| 0.07 | 0.044 | 0.072 | Matrix metalloproteinase inhibitor | 0.07 0.044 DBMET00733 0.072 0.042 DBMET00507 | DBMET00507 | |
| 0.056 | 0.029 | 0.066 | Vanilloid 2 antagonist | 0.066 0.017 DBMET00733 0.049 0.044 DBMET01018 | DBMET00733 | |
| 0.034 | 0.008 | 0.035 | Integrin alpha4beta7 antagonist | 0.023 0.013 DBMET00733 0.035 0.007 DBMET00507 | DBMET00507 | |
| 0.04 | 0.015 | 0.079 | AMPA 1 receptor antagonist | 0.041 0.014 DBMET00733 0.079 0.007 DBMET01437 0.053 0.01 DBMET00507 | DBMET01437 | |
| 0.085 | 0.059 | 0.117 | Transcription factor NF kappa B stimulant | 0.091 0.05 DBMET00733 0.087 0.056 DBMET00540 0.09 0.052 DBMET01018 0.117 0.027 DBMET01437 | DBMET01437 | |
| 0.03 | 0.005 | 0.03 | Dipeptidyl peptidase VIII inhibitor | 0.014 0.013 DBMET00733 | ||
| 0.078 | 0.053 | 0.098 | Na+ K+ transporting ATPase inhibitor | 0.088 0.043 DBMET00733 0.095 0.037 DBMET00540 0.081 0.049 DBMET02222 0.098 0.034 DBMET01018 0.098 0.033 DBMET01437 | DBMET01437 | |
| 0.048 | 0.023 | 0.048 | HIV-1 protease inhibitor | 0.048 0.024 DBMET00733 | ||
| 0.03 | 0.005 | 0.03 | Isoleucine-tRNA ligase inhibitor | 0.029 0.006 DBMET00733 0.027 0.008 DBMET00540 0.021 0.02 DBMET02222 0.025 0.01 DBMET01018 0.026 0.009 DBMET01437 | ||
| 0.06 | 0.035 | 0.173 | Carbonic anhydrase VB inhibitor | 0.074 0.025 DBMET00733 0.077 0.024 DBMET02222 0.173 0.007 DBMET01437 0.058 0.037 DBMET00507 | DBMET01437 | |
| 0.038 | 0.014 | 0.057 | Lysophosphatidic acid 2 receptor antagonist | 0.031 0.02 DBMET00733 0.047 0.009 DBMET00540 0.028 0.025 DBMET02222 0.034 0.017 DBMET01018 0.057 0.007 DBMET01437 0.033 0.018 DBMET00507 | DBMET01437 | |
| 0.035 | 0.01 | 0.041 | Purinergic P2Y15 antagonist | 0.031 0.015 DBMET00733 0.041 0.006 DBMET00540 0.029 0.02 DBMET02222 0.034 0.011 DBMET01018 0.033 0.013 DBMET01437 0.033 0.012 DBMET00507 | DBMET00540 | |
| 0.043 | 0.019 | 0.043 | Bombesin 1 receptor antagonist | 0.033 0.031 DBMET00733 | ||
| 0.139 | 0.115 | 0.159 | Tumour necrosis factor antagonist | 0.134 0.122 DBMET00733 0.159 0.089 DBMET01437 | DBMET01437 | |
| 0.029 | 0.004 | 0.053 | Nicotinic acid receptor 1 antagonist | 0.043 0.003 DBMET00733 0.016 0.014 DBMET00540 0.02 0.009 DBMET02222 0.022 0.007 DBMET01018 0.053 0.003 DBMET01437 | DBMET01437 | |
| 0.113 | 0.088 | 0.149 | DNA repair enzyme inhibitor | 0.111 0.093 DBMET00733 0.111 0.092 DBMET00540 0.111 0.094 DBMET02222 0.108 0.101 DBMET01018 0.149 0.032 DBMET01437 0.111 0.092 DBMET00507 | DBMET01437 | |
| 0.036 | 0.012 | 0.146 | Lysine carboxypeptidase inhibitor | 0.036 0.012 DBMET00733 0.03 0.016 DBMET00540 0.025 0.021 DBMET01018 0.043 0.009 DBMET01437 0.146 0.003 DBMET00507 | DBMET00507 | |
| 0.084 | 0.06 | 0.105 | Vanilloid agonist | 0.105 0.028 DBMET00733 0.078 0.076 DBMET02222 0.081 0.067 DBMET01018 | DBMET00733 | |
| 0.038 | 0.014 | 0.038 | Carboxypeptidase B inhibitor | 0.035 0.019 DBMET00733 0.034 0.02 DBMET00540 0.035 0.019 DBMET01437 0.036 0.017 DBMET00507 | ||
| 0.052 | 0.029 | 0.052 | Endothelin-converting enzyme inhibitor | |||
| 0.04 | 0.016 | 0.067 | Glutamate (mGluR4) agonist | 0.033 0.025 DBMET00733 0.067 0.007 DBMET01437 | DBMET01437 | |
| 0.144 | 0.121 | 0.372 | Pyruvate kinase inhibitor | 0.22 0.071 DBMET00733 0.309 0.046 DBMET00540 0.188 0.088 DBMET02222 0.372 0.027 DBMET01018 0.333 0.039 DBMET01437 | DBMET01018 | |
| 0.041 | 0.018 | 0.077 | Somatostatin 5 antagonist | 0.038 0.019 DBMET00733 0.044 0.016 DBMET00540 0.041 0.017 DBMET01018 0.077 0.008 DBMET01437 | DBMET01437 | |
| 0.031 | 0.008 | 0.035 | Acid ceramidase inhibitor | 0.029 0.01 DBMET00540 0.035 0.005 DBMET02222 | DBMET02222 | |
| 0.064 | 0.042 | 0.076 | Calcium channel P-type blocker | 0.076 0.018 DBMET02222 0.075 0.02 DBMET01437 | DBMET02222 | |
| 0.032 | 0.009 | 0.043 | Lysophosphatidic acid receptor 1 agonist | 0.023 0.022 DBMET00733 0.039 0.006 DBMET00540 0.03 0.011 DBMET02222 0.026 0.016 DBMET01018 0.043 0.005 DBMET01437 0.032 0.01 DBMET00507 | DBMET01437 | |
| 0.082 | 0.06 | 0.083 | Histamine H2 receptor antagonist | 0.083 0.058 DBMET01437 | DBMET01437 | |
| 0.057 | 0.035 | 0.057 | Matrix metalloproteinase (membrane-type) inhibitor | 0.054 0.04 DBMET00733 0.049 0.048 DBMET02222 0.054 0.039 DBMET00507 | ||
| 0.073 | 0.051 | 0.073 | Histone deacetylase SIRT2 inhibitor | |||
| 0.054 | 0.032 | 0.054 | Carbonic anhydrase II stimulant | |||
| 0.042 | 0.021 | 0.042 | Growth hormone secretagogue receptor antagonist | |||
| 0.037 | 0.016 | 0.052 | AMPA 2 receptor antagonist | 0.031 0.019 DBMET00733 0.052 0.01 DBMET01437 | DBMET01437 | |
| 0.047 | 0.026 | 0.071 | Leukocyte elastase inhibitor | 0.048 0.025 DBMET02222 0.071 0.014 DBMET01437 0.057 0.02 DBMET00507 | DBMET01437 | |
| 0.036 | 0.016 | 0.036 | Calpain 1 inhibitor | 0.032 0.028 DBMET00733 0.033 0.023 DBMET02222 | ||
| 0.072 | 0.052 | 0.079 | Metalloproteinase-9 inhibitor | 0.079 0.045 DBMET00733 0.077 0.046 DBMET00507 | DBMET00733 | |
| 0.029 | 0.009 | 0.032 | Complement factor 1s inhibitor | 0.025 0.019 DBMET02222 0.032 0.006 DBMET01437 | DBMET01437 | |
| 0.029 | 0.008 | 0.045 | Protease (Human cytomegalovirus) inhibitor | 0.025 0.011 DBMET02222 0.045 0.005 DBMET01437 | DBMET01437 | |
| 0.113 | 0.093 | 0.233 | Antibacterial (Helicobacter pylori) | 0.109 0.1 DBMET00733 0.134 0.062 DBMET00540 0.233 0.015 DBMET02222 0.133 0.064 DBMET01018 0.147 0.048 DBMET01437 0.111 0.095 DBMET00507 | DBMET02222 | |
| 0.033 | 0.013 | 0.033 | 5 Hydroxytryptamine 6 agonist | |||
| 0.028 | 0.007 | 0.028 | Histamine H4 receptor agonist | |||
| 0.041 | 0.022 | 0.041 | Cholecystokinin B agonist | 0.037 0.026 DBMET00733 | ||
| 0.046 | 0.027 | 0.097 | AICAR transformylase inhibitor | 0.047 0.026 DBMET00733 0.043 0.032 DBMET02222 0.085 0.006 DBMET01437 0.097 0.005 DBMET00507 | DBMET00507 | |
| 0.05 | 0.03 | 0.05 | Kallikrein inhibitor | |||
| 0.057 | 0.038 | 0.128 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.073 0.024 DBMET00540 0.072 0.024 DBMET02222 0.055 0.041 DBMET01018 0.128 0.01 DBMET01437 0.077 0.022 DBMET00507 | DBMET01437 | |
| 0.073 | 0.054 | 0.073 | Rho-associated kinase I inhibitor | |||
| 0.054 | 0.036 | 0.058 | Matrix metalloproteinase 1 inhibitor | 0.058 0.033 DBMET00733 0.047 0.041 DBMET00507 | DBMET00733 | |
| 0.028 | 0.01 | 0.028 | Integrin beta7 antagonist | 0.019 0.014 DBMET00733 0.028 0.01 DBMET00507 | ||
| 0.05 | 0.032 | 0.05 | Collagenase inhibitor | 0.049 0.035 DBMET00507 | ||
| 0.047 | 0.029 | 0.121 | Neuraminidase (Influenza A) inhibitor | 0.05 0.023 DBMET00733 0.065 0.009 DBMET00540 0.061 0.012 DBMET01018 0.121 0.004 DBMET01437 | DBMET01437 | |
| 0.045 | 0.027 | 0.071 | GABA B receptor antagonist | 0.039 0.037 DBMET00733 0.043 0.03 DBMET02222 0.071 0.008 DBMET01437 | DBMET01437 | |
| 0.078 | 0.06 | 0.078 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.038 | 0.02 | 0.059 | Ceramide glucosyltransferase inhibitor | 0.038 0.021 DBMET00733 0.059 0.004 DBMET00540 0.056 0.005 DBMET01018 0.035 0.027 DBMET01437 0.044 0.012 DBMET00507 | DBMET00540 | |
| 0.093 | 0.076 | 0.097 | Nav1.1 sodium channel blocker | 0.097 0.07 DBMET00733 | DBMET00733 | |
| 0.222 | 0.205 | 0.449 | Antibacterial | 0.292 0.142 DBMET00733 0.411 0.072 DBMET00540 0.292 0.141 DBMET02222 0.449 0.057 DBMET01018 0.435 0.062 DBMET01437 0.243 0.184 DBMET00507 | DBMET01018 | |
| 0.03 | 0.013 | 0.051 | Thyroid hormone agonist | 0.051 0.004 DBMET00733 0.029 0.013 DBMET02222 0.033 0.01 DBMET01018 0.027 0.016 DBMET01437 0.042 0.005 DBMET00507 | DBMET00733 | |
| 0.04 | 0.023 | 0.044 | Factor XIIIa inhibitor | 0.044 0.019 DBMET02222 0.042 0.021 DBMET00507 | DBMET02222 | |
| 0.05 | 0.033 | 0.05 | Metalloproteinase-3 inhibitor | 0.044 0.04 DBMET00733 0.049 0.034 DBMET00507 | ||
| 0.036 | 0.02 | 0.067 | Angiotensin II receptor antagonist | 0.031 0.029 DBMET02222 0.067 0.004 DBMET01437 0.034 0.024 DBMET00507 | DBMET01437 | |
| 0.034 | 0.017 | 0.034 | Plasmepsin I inhibitor | |||
| 0.078 | 0.062 | 0.078 | Protein kinase A inhibitor | |||
| 0.047 | 0.031 | 0.079 | Adenylate cyclase 1 inhibitor | 0.042 0.038 DBMET00733 0.075 0.01 DBMET02222 0.066 0.014 DBMET01437 0.079 0.008 DBMET00507 | DBMET00507 | |
| 0.055 | 0.04 | 0.108 | Sphingosine 1-phosphate receptor 1 antagonist | 0.055 0.039 DBMET00733 0.108 0.008 DBMET00540 0.061 0.027 DBMET02222 0.101 0.009 DBMET01018 0.07 0.018 DBMET01437 0.081 0.014 DBMET00507 | DBMET00540 | |
| 0.021 | 0.006 | 0.023 | Telomerase stimulant | 0.023 0.005 DBMET00733 0.023 0.005 DBMET00540 0.017 0.013 DBMET02222 0.023 0.005 DBMET01018 0.021 0.007 DBMET01437 | DBMET01018 | |
| 0.102 | 0.087 | 0.102 | Beta amyloid protein antagonist | 0.098 0.092 DBMET01437 | ||
| 0.034 | 0.019 | 0.034 | GHS receptor antagonist | |||
| 0.036 | 0.021 | 0.036 | Plasma kallikrein inhibitor | 0.03 0.027 DBMET02222 | ||
| 0.066 | 0.051 | 0.109 | MDM2 inhibitor | 0.073 0.031 DBMET02222 0.109 0.005 DBMET01437 0.072 0.033 DBMET00507 | DBMET01437 | |
| 0.049 | 0.035 | 0.054 | HCV NS3/NS4A protease inhibitor | 0.047 0.038 DBMET02222 0.052 0.029 DBMET01437 0.054 0.027 DBMET00507 | DBMET00507 | |
| 0.046 | 0.032 | 0.047 | Glutamate (mGluR5) agonist | 0.047 0.03 DBMET01437 | DBMET01437 | |
| 0.044 | 0.031 | 0.067 | Sphingosine 1-phosphate receptor agonist | 0.043 0.032 DBMET00540 0.067 0.013 DBMET01437 0.062 0.015 DBMET00507 | DBMET01437 | |
| 0.018 | 0.005 | 0.041 | Glutamate (mGluR6) agonist | 0.019 0.004 DBMET00733 0.018 0.005 DBMET00540 0.016 0.005 DBMET01018 0.041 0.002 DBMET01437 0.011 0.01 DBMET00507 | DBMET01437 | |
| 0.041 | 0.028 | 0.434 | Erythropoietin receptor agonist | 0.049 0.022 DBMET00733 0.039 0.03 DBMET01018 0.434 0.004 DBMET00507 | DBMET00507 | |
| 0.032 | 0.019 | 0.054 | Peptide deformylase inhibitor | 0.054 0.009 DBMET02222 0.045 0.012 DBMET00507 | DBMET02222 | |
| 0.029 | 0.016 | 0.029 | Urotensin II agonist | 0.027 0.018 DBMET00733 | ||
| 0.025 | 0.012 | 0.025 | Neurokinin 1 agonist | 0.018 0.016 DBMET00733 | ||
| 0.043 | 0.03 | 0.069 | Heme oxygenase inhibitor | 0.044 0.027 DBMET00540 0.069 0.004 DBMET02222 0.046 0.019 DBMET01437 | DBMET02222 | |
| 0.036 | 0.023 | 0.036 | Growth factor receptor-bound protein 2 antagonist | 0.035 0.024 DBMET00733 | ||
| 0.061 | 0.048 | 0.061 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.026 | 0.014 | 0.027 | Somatostatin 4 antagonist | 0.023 0.017 DBMET00733 0.027 0.013 DBMET00540 0.025 0.015 DBMET01018 | DBMET00540 | |
| 0.037 | 0.025 | 0.037 | Renin inhibitor | |||
| 0.03 | 0.018 | 0.03 | Histamine H3 receptor agonist | |||
| 0.058 | 0.046 | 0.11 | Potassium channel intermediate-conductance Ca-activated blocker | 0.058 0.045 DBMET02222 0.11 0.007 DBMET01437 | DBMET01437 | |
| 0.049 | 0.038 | 0.05 | Potassium channel (Inward rectifier) activator | 0.05 0.037 DBMET01437 | DBMET01437 | |
| 0.047 | 0.036 | 0.047 | Sigma receptor antagonist | |||
| 0.123 | 0.113 | 0.123 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.038 | 0.027 | 0.038 | Factor VIIa inhibitor | |||
| 0.024 | 0.013 | 0.048 | ICAM 1 antagonist | 0.022 0.017 DBMET00733 0.029 0.007 DBMET01437 0.048 0.004 DBMET00507 | DBMET00507 | |
| 0.047 | 0.036 | 0.047 | Potassium channel (ATP-sensitive) activator | 0.047 0.035 DBMET01437 | ||
| 0.037 | 0.027 | 0.037 | Carbonic anhydrase I stimulant | |||
| 0.04 | 0.03 | 0.04 | Histone deacetylase 8 inhibitor | |||
| 0.041 | 0.031 | 0.066 | Angiotensin AT1 receptor antagonist | 0.042 0.029 DBMET02222 0.066 0.004 DBMET01437 0.045 0.024 DBMET00507 | DBMET01437 | |
| 0.059 | 0.049 | 0.059 | I kappa B kinase 2 inhibitor | 0.057 0.054 DBMET00733 | ||
| 0.038 | 0.029 | 0.123 | GABA uptake inhibitor | 0.049 0.016 DBMET02222 0.123 0.003 DBMET01437 0.038 0.03 DBMET00507 | DBMET01437 | |
| 0.073 | 0.064 | 0.113 | Sphingosine 1-phosphate receptor antagonist | 0.073 0.062 DBMET00733 0.113 0.015 DBMET00540 0.094 0.026 DBMET02222 0.108 0.018 DBMET01018 0.102 0.02 DBMET01437 0.11 0.016 DBMET00507 | DBMET00540 | |
| 0.027 | 0.018 | 0.068 | Calcium-sensing receptor agonist | 0.068 0.004 DBMET01437 0.067 0.004 DBMET00507 | DBMET01437 | |
| 0.022 | 0.013 | 0.023 | Imidazoline I1 receptor antagonist | 0.023 0.012 DBMET02222 | DBMET02222 | |
| 0.046 | 0.037 | 0.105 | Glucose-6-phosphate isomerase inhibitor | 0.045 0.038 DBMET00733 0.053 0.025 DBMET00540 0.077 0.01 DBMET02222 0.047 0.035 DBMET01018 0.105 0.004 DBMET01437 0.074 0.01 DBMET00507 | DBMET01437 | |
| 0.027 | 0.018 | 0.096 | Nicotinic acid receptor 2 antagonist | 0.036 0.007 DBMET02222 0.096 0.002 DBMET01437 | DBMET01437 | |
| 0.02 | 0.011 | 0.026 | Antibiotic Anthracycline-like | 0.023 0.006 DBMET00733 0.023 0.007 DBMET00540 0.022 0.008 DBMET02222 0.026 0.005 DBMET01018 0.022 0.008 DBMET01437 | DBMET01018 | |
| 0.017 | 0.009 | 0.017 | CXC chemokine 4 receptor agonist | |||
| 0.056 | 0.048 | 0.059 | Gonadotropin-releasing hormone receptor agonist | 0.059 0.042 DBMET00733 0.057 0.046 DBMET00507 | DBMET00733 | |
| 0.063 | 0.055 | 0.063 | Potassium channel (ATP-sensitive) blocker | |||
| 0.098 | 0.09 | 0.269 | Cholesterol synthesis inhibitor | 0.126 0.06 DBMET00733 0.124 0.061 DBMET00540 0.16 0.04 DBMET02222 0.145 0.047 DBMET01018 0.269 0.015 DBMET01437 0.154 0.042 DBMET00507 | DBMET01437 | |
| 0.023 | 0.015 | 0.027 | Bombesin agonist | 0.027 0.01 DBMET01437 | DBMET01437 | |
| 0.019 | 0.012 | 0.034 | Estrogen-related receptor gamma agonist | 0.03 0.004 DBMET00733 0.022 0.008 DBMET02222 0.018 0.014 DBMET01018 0.019 0.012 DBMET01437 0.034 0.004 DBMET00507 | DBMET00507 | |
| 0.015 | 0.008 | 0.024 | Lysophosphatidic acid receptor 3 agonist | 0.024 0.004 DBMET00540 0.013 0.01 DBMET02222 0.013 0.01 DBMET01018 0.024 0.004 DBMET01437 | DBMET01437 | |
| 0.026 | 0.019 | 0.026 | Sigma 1 receptor antagonist | |||
| 0.042 | 0.035 | 0.179 | Dihydroorotase inhibitor | 0.046 0.029 DBMET02222 0.179 0.003 DBMET01437 0.052 0.022 DBMET00507 | DBMET01437 | |
| 0.022 | 0.016 | 0.022 | Geranylgeranyltransferase inhibitor | 0.02 0.018 DBMET01437 | ||
| 0.02 | 0.014 | 0.021 | Toll-Like receptor 8 agonist | 0.021 0.012 DBMET00540 | DBMET00540 | |
| 0.023 | 0.017 | 0.023 | Growth hormone releasing factor antagonist | 0.022 0.018 DBMET00733 | ||
| 0.027 | 0.021 | 0.03 | Hedgehog signaling activator | 0.026 0.025 DBMET00733 0.029 0.015 DBMET02222 0.03 0.013 DBMET01437 | DBMET01437 | |
| 0.085 | 0.079 | 0.121 | MAP kinase kinase 1 inhibitor | 0.085 0.078 DBMET00540 0.121 0.034 DBMET01437 | DBMET01437 | |
| 0.044 | 0.038 | 0.107 | AMPA receptor antagonist | 0.107 0.01 DBMET01437 | DBMET01437 | |
| 0.058 | 0.052 | 0.081 | Caspase 9 inhibitor | 0.066 0.037 DBMET02222 0.081 0.023 DBMET00507 | DBMET00507 | |
| 0.011 | 0.006 | 0.011 | Angiotensin AT2 receptor agonist | |||
| 0.026 | 0.021 | 0.026 | Myristoyl transferase inhibitor | |||
| 0.033 | 0.027 | 0.071 | Phosphoglycerate kinase inhibitor | 0.035 0.024 DBMET00733 0.04 0.02 DBMET00540 0.05 0.014 DBMET02222 0.038 0.021 DBMET01018 0.071 0.009 DBMET01437 | DBMET01437 | |
| 0.054 | 0.049 | 0.099 | Pregnane X receptor antagonist | 0.053 0.051 DBMET00733 0.057 0.039 DBMET00540 0.072 0.012 DBMET02222 0.055 0.045 DBMET01018 0.099 0.004 DBMET01437 | DBMET01437 | |
| 0.025 | 0.02 | 0.047 | Integrin alpha2beta1 antagonist | 0.047 0.005 DBMET01437 0.04 0.006 DBMET00507 | DBMET01437 | |
| 0.015 | 0.011 | 0.015 | Purinergic P2Y1 agonist | 0.015 0.011 DBMET00733 0.015 0.012 DBMET00540 0.014 0.013 DBMET01437 | ||
| 0.034 | 0.03 | 0.034 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.074 | 0.069 | 0.074 | Neuropeptide Y antagonist | |||
| 0.037 | 0.032 | 0.162 | Integrin antagonist | 0.162 0.009 DBMET00507 | DBMET00507 | |
| 0.022 | 0.017 | 0.083 | Beta 1 adrenoreceptor agonist | 0.032 0.007 DBMET00733 0.049 0.004 DBMET00540 0.083 0.003 DBMET01018 0.03 0.008 DBMET01437 | DBMET01018 | |
| 0.035 | 0.031 | 0.059 | Glutamate (mGluR group II) antagonist | 0.059 0.011 DBMET01437 | DBMET01437 | |
| 0.02 | 0.016 | 0.02 | Human T-cell leukemia virus type I protease inhibitor | |||
| 0.018 | 0.014 | 0.02 | Complement factor D inhibitor | 0.02 0.01 DBMET01437 | DBMET01437 | |
| 0.036 | 0.033 | 0.051 | Integrin alpha1beta1 antagonist | 0.051 0.007 DBMET00507 | DBMET00507 | |
| 0.018 | 0.016 | 0.018 | Somatostatin 3 antagonist | |||
| 0.034 | 0.031 | 0.082 | Integrin alpha2 antagonist | 0.063 0.006 DBMET01437 0.082 0.004 DBMET00507 | DBMET00507 | |
| 0.037 | 0.035 | 0.048 | Thymidine kinase inhibitor | 0.046 0.022 DBMET02222 0.047 0.021 DBMET01437 0.048 0.02 DBMET00507 | DBMET00507 | |
| 0.025 | 0.022 | 0.025 | Melanocortin 3 antagonist | |||
| 0.035 | 0.033 | 0.051 | Vascular adhesion protein 1 inhibitor | 0.051 0.015 DBMET00540 | DBMET00540 | |
| 0.027 | 0.025 | 0.037 | Estrogen-related receptor gamma antagonist | 0.036 0.008 DBMET00733 0.031 0.014 DBMET02222 0.031 0.013 DBMET01018 0.037 0.007 DBMET01437 | DBMET01437 | |
| 0.057 | 0.055 | 0.057 | 5 Hydroxytryptamine 3 agonist | |||
| 0.017 | 0.015 | 0.017 | Cyclin T1 inhibitor | |||
| 0.017 | 0.016 | 0.023 | Bombesin 3 receptor agonist | 0.023 0.009 DBMET01437 | DBMET01437 | |
| 0.028 | 0.026 | 0.028 | Somatostatin agonist | |||
| 0.029 | 0.027 | 0.036 | Trypsin I inhibitor | 0.036 0.02 DBMET00507 | DBMET00507 | |
| 0.01 | 0.009 | 0.01 | Melatonin 5 antagonist | |||
| 0.012 | 0.011 | 0.02 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.015 0.006 DBMET02222 0.015 0.006 DBMET01437 0.02 0.004 DBMET00507 | DBMET00507 | |
| 0.123 | 0.122 | 0.123 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.123 | 0.122 | 0.146 | Pregnane X receptor agonist | 0.141 0.072 DBMET00540 0.146 0.06 DBMET02222 0.133 0.09 DBMET01018 0.14 0.074 DBMET01437 | DBMET02222 | |
| 0.063 | 0.063 | 0.096 | Calcium channel L-type blocker | 0.071 0.051 DBMET02222 0.096 0.026 DBMET01437 | DBMET01437 | |
| 0.06 | 0.06 | 0.151 | Carbonic anhydrase VA inhibitor | 0.071 0.045 DBMET00733 0.08 0.036 DBMET02222 0.151 0.011 DBMET01437 0.084 0.034 DBMET00507 | DBMET01437 | |
| 0.015 | 0.016 | 0.016 | Angiotensin-converting enzyme 2 inhibitor | 0.016 0.015 DBMET00507 | DBMET00507 | |
| 0.064 | 0.064 | 0.24 | Carbonic anhydrase XIII inhibitor | 0.107 0.035 DBMET00733 0.098 0.039 DBMET02222 0.079 0.051 DBMET01018 0.24 0.009 DBMET01437 0.076 0.053 DBMET00507 | DBMET01437 | |
| 0.046 | 0.046 | 0.337 | CD45 antagonist | 0.051 0.033 DBMET00733 0.211 0.004 DBMET01437 0.337 0.004 DBMET00507 | DBMET00507 | |
| 0.116 | 0.117 | 0.266 | Insulin secretagoues | 0.138 0.087 DBMET00733 0.266 0.017 DBMET01437 0.197 0.038 DBMET00507 | DBMET01437 | |
| 0.023 | 0.024 | 0.078 | Uridine phosphorylase inhibitor | 0.036 0.014 DBMET02222 0.078 0.004 DBMET01437 0.026 0.021 DBMET00507 | DBMET01437 | |
| 0.04 | 0.041 | 0.126 | Thymidylate synthase inhibitor | 0.068 0.013 DBMET01437 0.126 0.004 DBMET00507 | DBMET00507 | |
| 0.014 | 0.015 | 0.05 | Carbonic anhydrase VIII inhibitor | 0.015 0.014 DBMET02222 0.05 0.003 DBMET01437 0.019 0.009 DBMET00507 | DBMET01437 | |
| 0.014 | 0.015 | 0.05 | Carbonic anhydrase X inhibitor | 0.015 0.014 DBMET02222 0.05 0.003 DBMET01437 0.019 0.009 DBMET00507 | DBMET01437 | |
| 0.054 | 0.055 | 0.113 | Selectin antagonist | 0.07 0.042 DBMET00733 0.059 0.051 DBMET00540 0.068 0.044 DBMET01018 0.113 0.024 DBMET01437 0.111 0.024 DBMET00507 | DBMET01437 | |
| 0.013 | 0.014 | 0.014 | NMDA receptor phencyclidine site antagonist | 0.014 0.013 DBMET00733 | DBMET00733 | |
| 0.017 | 0.018 | 0.018 | Alpha 2b adrenoreceptor agonist | 0.018 0.016 DBMET00540 0.018 0.014 DBMET02222 | DBMET02222 | |
| 0.014 | 0.016 | 0.018 | KiSS-1 receptor antagonist | 0.016 0.013 DBMET00733 0.018 0.011 DBMET02222 | DBMET02222 | |
| 0.033 | 0.035 | 0.059 | Alpha 1d adrenoreceptor agonist | 0.059 0.011 DBMET00540 0.038 0.028 DBMET02222 0.051 0.016 DBMET01018 0.052 0.015 DBMET01437 | DBMET00540 | |
| 0.035 | 0.038 | 0.073 | Integrin alpha5beta1 antagonist | 0.073 0.008 DBMET00507 | DBMET00507 | |
| 0.039 | 0.042 | 0.048 | Dihydrofolate reductase inhibitor | 0.047 0.022 DBMET01437 0.048 0.022 DBMET00507 | DBMET00507 | |
| 0.016 | 0.019 | 0.02 | Neutral endopeptidase inhibitor | 0.02 0.015 DBMET00507 | DBMET00507 | |
| 0.024 | 0.027 | 0.081 | LFA antagonist | 0.062 0.005 DBMET01437 0.081 0.004 DBMET00507 | DBMET00507 | |
| 0.006 | 0.009 | 0.008 | DNA topoisomerase III inhibitor | 0.007 0.005 DBMET02222 0.008 0.005 DBMET01437 | DBMET01437 | |
| 0.03 | 0.034 | 0.208 | Nicotinic acid receptor agonist | 0.042 0.019 DBMET00733 0.046 0.017 DBMET02222 0.208 0.003 DBMET01437 | DBMET01437 | |
| 0.056 | 0.061 | 0.076 | Acetylcholine M5 receptor agonist | 0.076 0.038 DBMET02222 0.059 0.057 DBMET01437 | DBMET02222 | |
| 0.055 | 0.061 | 0.168 | Carbonic anhydrase V inhibitor | 0.068 0.044 DBMET00733 0.076 0.038 DBMET02222 0.168 0.011 DBMET01437 0.082 0.034 DBMET00507 | DBMET01437 | |
| 0.016 | 0.023 | 0.028 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.016 DBMET02222 0.028 0.003 DBMET01437 0.021 0.008 DBMET00507 | DBMET01437 | |
| 0.037 | 0.044 | 0.093 | Nerve growth factor antagonist | 0.093 0.003 DBMET01437 | DBMET01437 | |
| 0.075 | 0.083 | 0.094 | mTOR complex 2 inhibitor | 0.082 0.063 DBMET00540 0.084 0.059 DBMET02222 0.078 0.075 DBMET01018 0.094 0.041 DBMET01437 | DBMET01437 | |
| 0.049 | 0.057 | 0.092 | Acetylcholine M3 receptor antagonist | 0.058 0.044 DBMET00733 0.079 0.026 DBMET00540 0.092 0.021 DBMET01018 | DBMET01018 | |
| 0.016 | 0.025 | 0.026 | Caspase 8 inhibitor | 0.021 0.011 DBMET01437 0.026 0.007 DBMET00507 | DBMET00507 | |
| 0.051 | 0.061 | 0.088 | Leukotriene C antagonist | 0.053 0.049 DBMET00733 0.067 0.017 DBMET02222 0.088 0.005 DBMET01437 0.071 0.013 DBMET00507 | DBMET01437 | |
| 0.017 | 0.027 | 0.023 | Factor XIII inhibitor | 0.023 0.01 DBMET02222 | DBMET02222 | |
| 0.008 | 0.019 | 0.03 | Angiotensin AT1B receptor antagonist | 0.03 0.004 DBMET01437 | DBMET01437 | |
| 0.027 | 0.037 | 0.067 | Free fatty acid receptor 1 antagonist | 0.044 0.012 DBMET02222 0.067 0.005 DBMET01437 | DBMET01437 | |
| 0.013 | 0.023 | 0.025 | Kainate receptor 3 antagonist | 0.025 0.007 DBMET01437 | DBMET01437 | |
| 0.047 | 0.058 | 0.138 | Dihydroorotate oxidase inhibitor | 0.052 0.046 DBMET00733 0.081 0.01 DBMET02222 0.138 0.003 DBMET01437 0.054 0.041 DBMET00507 | DBMET01437 | |
| 0.031 | 0.042 | 0.109 | Dihydropteroate synthase inhibitor | 0.039 0.028 DBMET00733 0.109 0.004 DBMET01437 0.075 0.007 DBMET00507 | DBMET01437 | |
| 0.029 | 0.04 | 0.162 | TRPM8 blocker | 0.162 0.004 DBMET01437 | DBMET01437 | |
| 0.039 | 0.051 | 0.067 | Aldosterone antagonist | 0.063 0.018 DBMET02222 0.067 0.015 DBMET01437 | DBMET01437 | |
| 0.033 | 0.045 | 0.052 | Opioid kappa receptor agonist | 0.052 0.023 DBMET00733 | DBMET00733 | |
| 0.056 | 0.069 | 0.064 | Elastase 1 inhibitor | 0.064 0.055 DBMET02222 0.064 0.055 DBMET01437 | DBMET01437 | |
| 0.012 | 0.025 | 0.016 | Thyroid hormone alpha agonist | 0.016 0.012 DBMET00733 | DBMET00733 | |
| 0.026 | 0.039 | 0.155 | Retinoid X alpha receptor agonist | 0.04 0.02 DBMET02222 0.155 0.003 DBMET01437 0.037 0.022 DBMET00507 | DBMET01437 | |
| 0.008 | 0.021 | 0.035 | Integrin beta2 antagonist | 0.015 0.006 DBMET01437 0.035 0.004 DBMET00507 | DBMET00507 | |
| 0.028 | 0.041 | 0.081 | Histone deacetylase 7 inhibitor | 0.081 0.011 DBMET02222 0.042 0.022 DBMET00507 | DBMET02222 | |
| 0.022 | 0.036 | 0.048 | Prostacyclin antagonist | 0.045 0.015 DBMET01437 0.048 0.014 DBMET00507 | DBMET00507 | |
| 0.027 | 0.042 | 0.038 | Melatonin receptor 1A agonist | 0.038 0.016 DBMET02222 0.038 0.016 DBMET01437 0.031 0.03 DBMET00507 | DBMET01437 | |
| 0.008 | 0.023 | 0.025 | Integrin alpha4beta1 antagonist | 0.025 0.008 DBMET00507 | DBMET00507 | |
| 0.017 | 0.032 | 0.064 | Retinoid X beta receptor antagonist | 0.022 0.011 DBMET02222 0.064 0.002 DBMET01437 | DBMET01437 | |
| 0.01 | 0.025 | 0.036 | Ileal bile acid transport inhibitor | 0.031 0.005 DBMET00540 0.036 0.004 DBMET01018 0.016 0.013 DBMET01437 0.021 0.008 DBMET00507 | DBMET01018 | |
| 0.03 | 0.045 | 0.053 | Calcium-independent phospholipase A2 inhibitor | 0.053 0.004 DBMET02222 0.052 0.004 DBMET01437 | DBMET02222 | |
| 0.033 | 0.049 | 0.078 | Guanylate cyclase inhibitor | 0.065 0.007 DBMET02222 0.078 0.003 DBMET01437 0.04 0.034 DBMET00507 | DBMET01437 | |
| 0.042 | 0.058 | 0.052 | Adenosine A1 receptor antagonist | 0.052 0.047 DBMET02222 | DBMET02222 | |
| 0.037 | 0.054 | 0.115 | Carbonic anhydrase XIV inhibitor | 0.053 0.03 DBMET00733 0.115 0.008 DBMET01437 0.067 0.021 DBMET00507 | DBMET01437 | |
| 0.021 | 0.038 | 0.028 | Thymidine phosphorylase inhibitor | 0.028 0.014 DBMET01437 | DBMET01437 | |
| 0.022 | 0.04 | 0.035 | Glutamate (mGluR2) antagonist | 0.035 0.014 DBMET01437 | DBMET01437 | |
| 0.004 | 0.022 | 0.011 | Thyroid hormone beta agonist | 0.008 0.007 DBMET00733 0.011 0.005 DBMET00507 | DBMET00507 | |
| 0.015 | 0.033 | 0.034 | Kainate receptor 4 antagonist | 0.034 0.012 DBMET01437 | DBMET01437 | |
| 0.016 | 0.034 | 0.027 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.027 0.005 DBMET02222 0.021 0.013 DBMET01437 | DBMET02222 | |
| 0.095 | 0.113 | 0.183 | Bone formation stimulant | 0.153 0.056 DBMET00733 0.131 0.076 DBMET01437 0.183 0.041 DBMET00507 | DBMET00507 | |
| 0.012 | 0.031 | 0.082 | Kainate receptor 5 antagonist | 0.082 0.004 DBMET01437 | DBMET01437 | |
| 0.015 | 0.034 | 0.056 | Lysophosphatidic acid 1 receptor antagonist | 0.02 0.016 DBMET00540 0.056 0.004 DBMET01437 0.021 0.015 DBMET00507 | DBMET01437 | |
| 0.005 | 0.024 | 0.03 | Beta 3 adrenoreceptor agonist | 0.015 0.005 DBMET00540 0.03 0.004 DBMET01018 0.01 0.009 DBMET01437 | DBMET01018 | |
| 0.043 | 0.062 | 0.102 | Leukotriene B4 antagonist | 0.051 0.041 DBMET00733 0.055 0.035 DBMET00540 0.052 0.04 DBMET02222 0.06 0.028 DBMET01018 0.102 0.01 DBMET01437 | DBMET01437 | |
| 0.017 | 0.037 | 0.027 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.027 0.01 DBMET01437 | DBMET01437 | |
| 0.004 | 0.024 | 0.009 | Integrin alpha5beta6 antagonist | 0.006 0.005 DBMET01437 0.009 0.003 DBMET00507 | DBMET00507 | |
| 0.01 | 0.03 | 0.022 | Alpha 2a adrenoreceptor agonist | 0.022 0.008 DBMET00540 0.019 0.01 DBMET01018 | DBMET00540 | |
| 0.029 | 0.049 | 0.1 | Carbonic anhydrase IV inhibitor | 0.063 0.018 DBMET01437 0.1 0.007 DBMET00507 | DBMET00507 | |
| 0.022 | 0.042 | 0.029 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.021 DBMET02222 0.029 0.012 DBMET01437 | DBMET01437 | |
| 0.028 | 0.049 | 0.033 | HCV polyprotein inhibitor | 0.033 0.025 DBMET01437 0.032 0.031 DBMET00507 | DBMET01437 | |
| 0.034 | 0.055 | 0.069 | Fructose-1,6-bisphosphatase inhibitor | 0.069 0.013 DBMET01437 | DBMET01437 | |
| 0.061 | 0.082 | 0.111 | Peroxisome proliferator-activated receptor gamma antagonist | 0.073 0.046 DBMET02222 0.111 0.011 DBMET01437 0.099 0.016 DBMET00507 | DBMET01437 | |
| 0.039 | 0.061 | 0.121 | Maillard reaction inhibitor | 0.078 0.026 DBMET00733 0.079 0.025 DBMET00540 0.1 0.017 DBMET01018 0.121 0.01 DBMET01437 | DBMET01437 | |
| 0.015 | 0.039 | 0.03 | Prostaglandin F2 alpha agonist | 0.027 0.011 DBMET02222 0.03 0.009 DBMET01437 | DBMET01437 | |
| 0.04 | 0.063 | 0.081 | Squalene epoxidase inhibitor | 0.053 0.029 DBMET02222 0.081 0.009 DBMET01437 | DBMET01437 | |
| 0.021 | 0.046 | 0.055 | Cholecystokinin antagonist | 0.055 0.022 DBMET00507 | DBMET00507 | |
| 0.031 | 0.055 | 0.118 | GP IIb/IIIa receptor antagonist | 0.118 0.014 DBMET00507 | DBMET00507 | |
| 0.11 | 0.135 | 0.345 | Hexokinase inhibitor | 0.132 0.102 DBMET00733 0.214 0.028 DBMET02222 0.345 0.007 DBMET01437 0.162 0.066 DBMET00507 | DBMET01437 | |
| 0.047 | 0.073 | 0.07 | Heat shock protein 90 beta antagonist | 0.07 0.028 DBMET00733 0.055 0.048 DBMET01437 0.061 0.038 DBMET00507 | DBMET00733 | |
| 0.007 | 0.033 | 0.022 | Carbonic anhydrase XI inhibitor | 0.022 0.004 DBMET01437 | DBMET01437 | |
| 0.029 | 0.056 | 0.203 | Phosphorylase inhibitor | 0.129 0.009 DBMET01437 0.203 0.005 DBMET00507 | DBMET00507 | |
| 0.096 | 0.123 | 0.109 | Calcium channel blocker | 0.109 0.1 DBMET01437 | DBMET01437 | |
| 0.015 | 0.042 | 0.029 | Cholecystokinin B antagonist | 0.029 0.022 DBMET00507 | DBMET00507 | |
| 0.013 | 0.041 | 0.042 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.042 0.011 DBMET01437 0.037 0.013 DBMET00507 | DBMET01437 | |
| 0.011 | 0.039 | 0.021 | Vitamin D receptor agonist | 0.021 0.006 DBMET00507 | DBMET00507 | |
| 0.028 | 0.056 | 0.066 | Glutamate (mGluR1a) antagonist | 0.066 0.013 DBMET01437 0.044 0.025 DBMET00507 | DBMET01437 | |
| 0.021 | 0.049 | 0.049 | Epoxide hydrolase 1 inhibitor | 0.049 0.006 DBMET01437 0.04 0.011 DBMET00507 | DBMET01437 | |
| 0.004 | 0.032 | 0.014 | Integrin alphaVbeta5 antagonist | 0.014 0.005 DBMET00507 | DBMET00507 | |
| 0.035 | 0.064 | 0.057 | Purinergic P2X4 antagonist | 0.042 0.039 DBMET02222 0.057 0.017 DBMET01437 | DBMET01437 | |
| 0.039 | 0.068 | 0.066 | Cannabinoid CB1 receptor agonist | 0.066 0.038 DBMET00507 | DBMET00507 | |
| 0.032 | 0.061 | 0.063 | Leukotriene C4 antagonist | 0.045 0.016 DBMET02222 0.063 0.005 DBMET01437 0.046 0.014 DBMET00507 | DBMET01437 | |
| 0.009 | 0.039 | 0.021 | Thromboxane A2 agonist | 0.021 0.005 DBMET01437 0.02 0.005 DBMET00507 | DBMET01437 | |
| 0.063 | 0.092 | 0.095 | Alpha 2 adrenoreceptor antagonist | 0.095 0.052 DBMET00540 0.088 0.057 DBMET01018 | DBMET00540 | |
| 0.054 | 0.083 | 0.066 | Transcription factor RelA inhibitor | 0.061 0.051 DBMET02222 0.066 0.037 DBMET01437 | DBMET01437 | |
| 0.005 | 0.035 | 0.017 | Thromboxane agonist | 0.013 0.005 DBMET02222 0.017 0.004 DBMET01437 | DBMET01437 | |
| 0.007 | 0.038 | 0.02 | Integrin alphaVbeta6 antagonist | 0.02 0.006 DBMET00507 | DBMET00507 | |
| 0.049 | 0.079 | 0.071 | Histone deacetylase inhibitor | 0.071 0.039 DBMET02222 0.064 0.047 DBMET00507 | DBMET02222 | |
| 0.007 | 0.037 | 0.016 | Calcium-dependent phospholipase A2 inhibitor | 0.016 0.005 DBMET02222 | DBMET02222 | |
| 0.026 | 0.057 | 0.085 | Protein kinase (CK2) beta inhibitor | 0.085 0.004 DBMET01437 | DBMET01437 | |
| 0.035 | 0.067 | 0.046 | Potassium channel (Inward rectifier) blocker | 0.046 0.04 DBMET00540 | DBMET00540 | |
| 0.039 | 0.071 | 0.127 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.067 0.024 DBMET00733 0.066 0.025 DBMET02222 0.053 0.038 DBMET01018 0.127 0.007 DBMET01437 | DBMET01437 | |
| 0.042 | 0.074 | 0.073 | Androgen agonist | 0.057 0.046 DBMET00733 0.054 0.05 DBMET00540 0.066 0.034 DBMET02222 0.064 0.037 DBMET01018 0.073 0.028 DBMET01437 0.054 0.049 DBMET00507 | DBMET01437 | |
| 0.015 | 0.048 | 0.028 | CXC chemokine 2 receptor antagonist | 0.028 0.017 DBMET01437 | DBMET01437 | |
| 0.041 | 0.074 | 0.101 | Factor III inhibitor | 0.052 0.03 DBMET00733 0.052 0.03 DBMET01018 0.101 0.005 DBMET01437 0.071 0.01 DBMET00507 | DBMET01437 | |
| 0.052 | 0.085 | 0.108 | Protein kinase C beta inhibitor | 0.069 0.05 DBMET00540 0.07 0.048 DBMET01018 0.108 0.01 DBMET01437 | DBMET01437 | |
| 0.026 | 0.061 | 0.039 | Delayed rectifier potassium channel blocker | 0.037 0.027 DBMET02222 0.039 0.023 DBMET00507 | DBMET00507 | |
| 0.041 | 0.075 | 0.089 | Heparanase inhibitor | 0.073 0.01 DBMET02222 0.089 0.005 DBMET01437 0.076 0.008 DBMET00507 | DBMET01437 | |
| 0.029 | 0.063 | 0.057 | Histone deacetylase 9 inhibitor | 0.057 0.013 DBMET02222 0.042 0.023 DBMET00507 | DBMET02222 | |
| 0.042 | 0.077 | 0.078 | Acetylcholine M5 receptor antagonist | 0.078 0.025 DBMET00540 0.057 0.047 DBMET02222 0.069 0.032 DBMET01018 | DBMET00540 | |
| 0.063 | 0.098 | 0.285 | Potassium channel (Ca-activated) activator | 0.101 0.054 DBMET00733 0.285 0.005 DBMET01437 0.164 0.024 DBMET00507 | DBMET01437 | |
| 0.019 | 0.055 | 0.118 | 5-Alpha-reductase inhibitor | 0.033 0.031 DBMET02222 0.118 0.008 DBMET01437 0.035 0.028 DBMET00507 | DBMET01437 | |
| 0.024 | 0.06 | 0.071 | Retinoid X alpha receptor antagonist | 0.034 0.024 DBMET02222 0.071 0.003 DBMET01437 | DBMET01437 | |
| 0.018 | 0.054 | 0.131 | Retinoid X receptor agonist | 0.035 0.025 DBMET02222 0.131 0.003 DBMET01437 0.033 0.027 DBMET00507 | DBMET01437 | |
| 0.011 | 0.048 | 0.105 | 5-Alpha-reductase 2 inhibitor | 0.105 0.005 DBMET01437 | DBMET01437 | |
| 0.023 | 0.06 | 0.052 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.052 0.008 DBMET01437 | DBMET01437 | |
| 0.118 | 0.156 | 0.183 | MAP kinase kinase 2 inhibitor | 0.183 0.093 DBMET01437 0.151 0.121 DBMET00507 | DBMET01437 | |
| 0.049 | 0.088 | 0.09 | Ryanodine receptor antagonist | 0.06 0.036 DBMET02222 0.09 0.005 DBMET01437 0.065 0.025 DBMET00507 | DBMET01437 | |
| 0.026 | 0.066 | 0.082 | Retinoid X receptor antagonist | 0.038 0.026 DBMET02222 0.082 0.003 DBMET01437 | DBMET01437 | |
| 0.041 | 0.081 | 0.078 | Glucosylceramidase inhibitor | 0.078 0.017 DBMET00540 0.064 0.026 DBMET01018 0.061 0.03 DBMET01437 | DBMET00540 | |
| 0.03 | 0.071 | 0.072 | Glucagon-like peptide 1 receptor antagonist | 0.041 0.024 DBMET01437 0.072 0.006 DBMET00507 | DBMET00507 | |
| 0.012 | 0.052 | 0.023 | CXC chemokine 5 receptor antagonist | 0.023 0.005 DBMET01437 | DBMET01437 | |
| 0.017 | 0.059 | 0.024 | Sodium/glucose cotransporter inhibitor | 0.024 0.021 DBMET01437 | DBMET01437 | |
| 0.091 | 0.134 | 0.185 | Alkaline phosphatase inhibitor | 0.12 0.086 DBMET00733 0.185 0.039 DBMET01437 0.143 0.065 DBMET00507 | DBMET01437 | |
| 0.008 | 0.051 | 0.049 | Angiotensin AT2 receptor antagonist | 0.049 0.01 DBMET01437 | DBMET01437 | |
| 0.015 | 0.058 | 0.025 | Sodium/glucose cotransporter 2 inhibitor | 0.024 0.022 DBMET02222 0.025 0.02 DBMET01437 | DBMET01437 | |
| 0.023 | 0.067 | 0.039 | Macrophage elastase inhibitor | 0.039 0.035 DBMET00507 | DBMET00507 | |
| 0.081 | 0.126 | 0.165 | Glutamate receptor antagonist | 0.165 0.041 DBMET01437 | DBMET01437 | |
| 0.035 | 0.08 | 0.05 | Benzodiazepine antagonist | 0.05 0.026 DBMET02222 0.045 0.038 DBMET01437 | DBMET02222 | |
| 0.007 | 0.053 | 0.086 | 5-Alpha-reductase 1 inhibitor | 0.086 0.005 DBMET01437 | DBMET01437 | |
| 0.019 | 0.065 | 0.061 | ATP citrate lysase inhibitor | 0.034 0.019 DBMET02222 0.061 0.005 DBMET01437 | DBMET01437 | |
| 0.038 | 0.085 | 0.092 | TRPA1 antagonist | 0.092 0.02 DBMET02222 0.054 0.052 DBMET01437 | DBMET02222 | |
| 0.024 | 0.072 | 0.082 | Factor XIa inhibitor | 0.082 0.008 DBMET01437 | DBMET01437 | |
| 0.023 | 0.072 | 0.093 | Glycine transporter inhibitor | 0.093 0.013 DBMET00507 | DBMET00507 | |
| 0.011 | 0.059 | 0.031 | Integrin alphaVbeta1 antagonist | 0.031 0.005 DBMET00507 | DBMET00507 | |
| 0.063 | 0.112 | 0.095 | Caspase 7 inhibitor | 0.095 0.034 DBMET02222 0.088 0.045 DBMET01437 0.088 0.045 DBMET00507 | DBMET02222 | |
| 0.029 | 0.078 | 0.044 | Vanilloid 3 antagonist | 0.04 0.022 DBMET02222 0.044 0.014 DBMET01437 | DBMET01437 | |
| 0.004 | 0.053 | 0.102 | Prostaglandin EP4 agonist | 0.014 0.01 DBMET02222 0.102 0.004 DBMET01437 | DBMET01437 | |
| 0.012 | 0.063 | 0.038 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.038 0.012 DBMET01437 | DBMET01437 | |
| 0.01 | 0.061 | 0.062 | NMDA receptor glycine site antagonist | 0.062 0.005 DBMET01437 0.024 0.017 DBMET00507 | DBMET01437 | |
| 0.036 | 0.087 | 0.088 | Glutamate (mGluR) agonist | 0.088 0.027 DBMET01437 | DBMET01437 | |
| 0.005 | 0.057 | 0.026 | Human herpes virus 5 capsid protein P40 inhibitor | 0.026 0.004 DBMET01437 | DBMET01437 | |
| 0.02 | 0.074 | 0.04 | Histone deacetylase class I inhibitor | 0.04 0.026 DBMET02222 | DBMET02222 | |
| 0.008 | 0.062 | 0.053 | Prostaglandin H2 antagonist | 0.053 0.004 DBMET01437 0.035 0.009 DBMET00507 | DBMET01437 | |
| 0.065 | 0.12 | 0.117 | Gastric antisecretory | 0.117 0.046 DBMET01437 | DBMET01437 | |
| 0.086 | 0.141 | 0.246 | NADPH oxidase inhibitor | 0.113 0.092 DBMET00733 0.107 0.102 DBMET01018 0.246 0.022 DBMET01437 0.127 0.074 DBMET00507 | DBMET01437 | |
| 0.015 | 0.071 | 0.22 | NMDA 2D receptor antagonist | 0.22 0.003 DBMET01437 | DBMET01437 | |
| 0.013 | 0.07 | 0.022 | Protein 30S ribosomal subunit inhibitor | 0.022 0.019 DBMET01018 | DBMET01018 | |
| 0.037 | 0.095 | 0.077 | Collagenase 3 inhibitor | 0.077 0.027 DBMET01437 0.067 0.034 DBMET00507 | DBMET01437 | |
| 0.004 | 0.063 | 0.022 | Thrombopoietin agonist | 0.022 0.004 DBMET01437 | DBMET01437 | |
| 0.044 | 0.104 | 0.058 | Phosphodiesterase 1A inhibitor | 0.058 0.046 DBMET01437 | DBMET01437 | |
| 0.044 | 0.104 | 0.217 | Neuraminidase (influenza) inhibitor | 0.067 0.04 DBMET00733 0.111 0.014 DBMET00540 0.126 0.01 DBMET01018 0.217 0.004 DBMET01437 | DBMET01437 | |
| 0.033 | 0.093 | 0.103 | Factor IXa inhibitor | 0.103 0.009 DBMET00540 0.093 0.012 DBMET01018 0.087 0.014 DBMET01437 | DBMET00540 | |
| 0.033 | 0.095 | 0.116 | Topoisomerase II beta inhibitor | 0.056 0.025 DBMET02222 0.116 0.007 DBMET01437 0.078 0.014 DBMET00507 | DBMET01437 | |
| 0.047 | 0.109 | 0.118 | Epoxide hydrolase inhibitor | 0.084 0.038 DBMET02222 0.088 0.034 DBMET01437 0.118 0.018 DBMET00507 | DBMET00507 | |
| 0.01 | 0.074 | 0.015 | Antibiotic Tetracycline-like | 0.015 0.01 DBMET02222 | DBMET02222 | |
| 0.007 | 0.071 | 0.021 | Integrin beta3 antagonist | 0.021 0.012 DBMET00507 | DBMET00507 | |
| 0.016 | 0.08 | 0.046 | Cholesterol ester transfer protein antagonist | 0.029 0.025 DBMET02222 0.046 0.009 DBMET01437 | DBMET01437 | |
| 0.062 | 0.127 | 0.084 | Phosphodiesterase I inhibitor | 0.084 0.069 DBMET01437 | DBMET01437 | |
| 0.038 | 0.104 | 0.086 | Sphingosine 1-phosphate receptor 5 agonist | 0.078 0.013 DBMET01437 0.086 0.011 DBMET00507 | DBMET00507 | |
| 0.02 | 0.086 | 0.107 | RNA-directed RNA polymerase inhibitor | 0.107 0.005 DBMET01437 0.064 0.009 DBMET00507 | DBMET01437 | |
| 0.009 | 0.076 | 0.016 | CC chemokine 9 receptor antagonist | 0.016 0.014 DBMET01437 | DBMET01437 | |
| 0.004 | 0.071 | 0.022 | G-protein-coupled receptor 120 agonist | 0.022 0.008 DBMET01437 | DBMET01437 | |
| 0.004 | 0.071 | 0.014 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.014 0.011 DBMET01437 | DBMET01437 | |
| 0.043 | 0.111 | 0.057 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.057 0.051 DBMET01437 | DBMET01437 | |
| 0.108 | 0.177 | 0.146 | MAP kinase 3 inhibitor | 0.146 0.074 DBMET01437 | DBMET01437 | |
| 0.05 | 0.119 | 0.068 | Adenosine A3 receptor antagonist | 0.068 0.062 DBMET01437 | DBMET01437 | |
| 0.042 | 0.111 | 0.07 | Acetylcholine M4 receptor antagonist | 0.07 0.057 DBMET02222 | DBMET02222 | |
| 0.012 | 0.082 | 0.091 | HCV NS5B polymerase inhibitor | 0.091 0.005 DBMET01437 0.046 0.011 DBMET00507 | DBMET01437 | |
| 0.034 | 0.105 | 0.176 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.053 0.048 DBMET00733 0.176 0.005 DBMET01437 0.06 0.04 DBMET00507 | DBMET01437 | |
| 0.016 | 0.087 | 0.063 | Carnitine palmitoyltransferase inhibitor | 0.063 0.005 DBMET01437 0.034 0.024 DBMET00507 | DBMET01437 | |
| 0.007 | 0.078 | 0.064 | Prostaglandin EP2 agonist | 0.064 0.004 DBMET01437 0.021 0.017 DBMET00507 | DBMET01437 | |
| 0.004 | 0.075 | 0.049 | Peroxisome proliferator-activated receptor alpha antagonist | 0.049 0.008 DBMET01437 | DBMET01437 | |
| 0.03 | 0.102 | 0.19 | Neuraminidase inhibitor | 0.059 0.045 DBMET00733 0.102 0.015 DBMET00540 0.108 0.013 DBMET01018 0.19 0.004 DBMET01437 | DBMET01437 | |
| 0.043 | 0.114 | 0.185 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.072 0.058 DBMET00733 0.11 0.033 DBMET02222 0.185 0.011 DBMET01437 0.077 0.054 DBMET00507 | DBMET01437 | |
| 0.018 | 0.09 | 0.051 | Factor XI inhibitor | 0.051 0.01 DBMET01437 | DBMET01437 | |
| 0.012 | 0.084 | 0.059 | Liver X receptor beta antagonist | 0.059 0.006 DBMET01437 | DBMET01437 | |
| 0.022 | 0.095 | 0.055 | Potassium channel Kv1.3 blocker | 0.049 0.031 DBMET02222 0.043 0.038 DBMET01437 0.055 0.025 DBMET00507 | DBMET00507 | |
| 0.017 | 0.09 | 0.061 | Carnitine palmitoyltransferase 1 inhibitor | 0.061 0.005 DBMET01437 0.033 0.026 DBMET00507 | DBMET01437 | |
| 0.1 | 0.173 | 0.175 | Heat shock protein 90 alpha antagonist | 0.147 0.09 DBMET00733 0.175 0.066 DBMET01437 | DBMET01437 | |
| 0.127 | 0.2 | 0.236 | Histone acetyltransferase inhibitor | 0.191 0.083 DBMET02222 0.236 0.032 DBMET01437 0.188 0.088 DBMET00507 | DBMET01437 | |
| 0.045 | 0.119 | 0.074 | Phosphodiesterase 1C inhibitor | 0.074 0.024 DBMET01437 | DBMET01437 | |
| 0.066 | 0.141 | 0.26 | Xanthine oxidase inhibitor | 0.097 0.063 DBMET00733 0.089 0.073 DBMET01018 0.26 0.011 DBMET01437 0.087 0.077 DBMET00507 | DBMET01437 | |
| 0.071 | 0.146 | 0.113 | Toll-Like receptor 4 antagonist | 0.113 0.051 DBMET00733 0.103 0.064 DBMET01018 0.106 0.06 DBMET01437 | DBMET00733 | |
| 0.124 | 0.2 | 0.4 | Vasodilator | 0.178 0.123 DBMET00733 0.397 0.024 DBMET00540 0.348 0.034 DBMET02222 0.4 0.023 DBMET01018 0.218 0.091 DBMET01437 | DBMET01018 | |
| 0.015 | 0.091 | 0.037 | 1,3-Beta-glucan synthase inhibitor | 0.035 0.006 DBMET00540 0.037 0.005 DBMET01018 | DBMET01018 | |
| 0.014 | 0.091 | 0.032 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.032 0.022 DBMET02222 0.03 0.024 DBMET01437 | DBMET02222 | |
| 0.048 | 0.125 | 0.201 | Macrophage migration inhibitory factor inhibitor | 0.091 0.04 DBMET00733 0.136 0.02 DBMET02222 0.201 0.008 DBMET01437 | DBMET01437 | |
| 0.041 | 0.117 | 0.163 | Adenine nucleotide translocase inhibitor | 0.057 0.034 DBMET00733 0.057 0.034 DBMET01018 0.163 0.003 DBMET01437 0.067 0.018 DBMET00507 | DBMET01437 | |
| 0.028 | 0.106 | 0.055 | Cholesterol esterase inhibitor | 0.051 0.029 DBMET02222 0.055 0.023 DBMET01437 | DBMET01437 | |
| 0.028 | 0.106 | 0.07 | Elastase inhibitor | 0.07 0.022 DBMET02222 0.049 0.044 DBMET00507 | DBMET02222 | |
| 0.035 | 0.113 | 0.101 | Thromboxane synthase inhibitor | 0.101 0.006 DBMET01437 0.086 0.009 DBMET00507 | DBMET01437 | |
| 0.055 | 0.134 | 0.198 | Mediator release inhibitor | 0.103 0.067 DBMET02222 0.198 0.015 DBMET01437 0.11 0.058 DBMET00507 | DBMET01437 | |
| 0.017 | 0.095 | 0.075 | Carbonic anhydrase VII inhibitor | 0.05 0.028 DBMET02222 0.075 0.014 DBMET01437 0.059 0.02 DBMET00507 | DBMET01437 | |
| 0.044 | 0.123 | 0.086 | Alpha 2a adrenoreceptor antagonist | 0.086 0.044 DBMET00540 0.086 0.044 DBMET01018 | DBMET01018 | |
| 0.009 | 0.088 | 0.118 | Kynurenine 3 monooxygenase inhibitor | 0.118 0.003 DBMET01437 | DBMET01437 | |
| 0.01 | 0.089 | 0.148 | Glucagon receptor antagonist | 0.148 0.004 DBMET00507 | DBMET00507 | |
| 0.041 | 0.12 | 0.075 | Histamine H1 receptor antagonist | 0.075 0.062 DBMET01437 | DBMET01437 | |
| 0.021 | 0.101 | 0.094 | Thromboxane A2 antagonist | 0.094 0.009 DBMET01437 0.063 0.026 DBMET00507 | DBMET01437 | |
| 0.02 | 0.1 | 0.093 | Carbonic anhydrase I inhibitor | 0.049 0.044 DBMET02222 0.077 0.026 DBMET01437 0.093 0.02 DBMET00507 | DBMET00507 | |
| 0.198 | 0.279 | 0.525 | Cyclophilin D inhibitor | 0.279 0.182 DBMET00733 0.415 0.083 DBMET00540 0.41 0.085 DBMET01018 0.525 0.043 DBMET01437 0.425 0.078 DBMET00507 | DBMET01437 | |
| 0.016 | 0.097 | 0.092 | Glutamate (mGluR group II) agonist | 0.092 0.008 DBMET01437 | DBMET01437 | |
| 0.197 | 0.279 | 0.434 | Apoptosis agonist | 0.343 0.143 DBMET00733 0.434 0.098 DBMET02222 0.261 0.203 DBMET01018 0.28 0.187 DBMET01437 | DBMET02222 | |
| 0.027 | 0.109 | 0.104 | Diacylglycerol O-acyltransferase inhibitor | 0.089 0.01 DBMET01437 0.104 0.006 DBMET00507 | DBMET00507 | |
| 0.034 | 0.116 | 0.129 | Leukotriene antagonist | 0.057 0.054 DBMET01018 0.129 0.014 DBMET01437 0.069 0.041 DBMET00507 | DBMET01437 | |
| 0.037 | 0.12 | 0.054 | Phosphodiesterase 1B inhibitor | 0.054 0.052 DBMET01437 | DBMET01437 | |
| 0.027 | 0.111 | 0.097 | Alpha 1 adrenoreceptor agonist | 0.097 0.018 DBMET00540 0.089 0.02 DBMET01018 | DBMET00540 | |
| 0.059 | 0.144 | 0.109 | Alpha 2c adrenoreceptor antagonist | 0.109 0.058 DBMET00540 0.102 0.064 DBMET01018 | DBMET00540 | |
| 0.011 | 0.095 | 0.089 | Prostaglandin agonist | 0.037 0.015 DBMET02222 0.089 0.006 DBMET01437 | DBMET01437 | |
| 0.008 | 0.094 | 0.039 | Squalene synthetase inhibitor | 0.039 0.018 DBMET01437 | DBMET01437 | |
| 0.054 | 0.141 | 0.086 | Potassium channel activator | 0.086 0.067 DBMET01437 | DBMET01437 | |
| 0.089 | 0.176 | 0.25 | Amyloid beta aggregation inhibitor | 0.25 0.058 DBMET00733 0.169 0.095 DBMET01018 | DBMET00733 | |
| 0.031 | 0.119 | 0.133 | Glucose-6-phosphate translocase inhibitor | 0.133 0.004 DBMET02222 0.067 0.017 DBMET01437 | DBMET02222 | |
| 0.011 | 0.099 | 0.098 | Prostaglandin EP4 antagonist | 0.098 0.004 DBMET01437 0.03 0.015 DBMET00507 | DBMET01437 | |
| 0.102 | 0.19 | 0.222 | Hepatoprotectant | 0.17 0.09 DBMET00733 0.14 0.121 DBMET00540 0.197 0.067 DBMET02222 0.18 0.08 DBMET01018 0.222 0.053 DBMET01437 0.197 0.067 DBMET00507 | DBMET01437 | |
| 0.006 | 0.094 | 0.018 | Integrin alphaLbeta2 antagonist | 0.018 0.005 DBMET00507 | DBMET00507 | |
| 0.023 | 0.112 | 0.105 | Thromboxane antagonist | 0.105 0.01 DBMET01437 0.067 0.028 DBMET00507 | DBMET01437 | |
| 0.005 | 0.095 | 0.063 | Prostaglandin E2 agonist | 0.022 0.018 DBMET02222 0.063 0.005 DBMET01437 | DBMET01437 | |
| 0.009 | 0.1 | 0.038 | Integrin alphaVbeta3 antagonist | 0.038 0.005 DBMET00507 | DBMET00507 | |
| 0.066 | 0.158 | 0.148 | Toll-Like receptor 3 antagonist | 0.148 0.015 DBMET00540 0.127 0.025 DBMET01018 | DBMET00540 | |
| 0.062 | 0.155 | 0.213 | DNA polymerase I inhibitor | 0.126 0.064 DBMET00733 0.106 0.08 DBMET01018 0.213 0.024 DBMET01437 0.125 0.065 DBMET00507 | DBMET01437 | |
| 0.032 | 0.127 | 0.073 | Fatty acid synthase inhibitor | 0.073 0.023 DBMET01437 | DBMET01437 | |
| 0.018 | 0.113 | 0.065 | Oleamide hydrolase inhibitor | 0.065 0.018 DBMET02222 0.056 0.023 DBMET01437 | DBMET02222 | |
| 0.02 | 0.119 | 0.058 | Liver X receptor alpha agonist | 0.058 0.014 DBMET01437 | DBMET01437 | |
| 0.016 | 0.116 | 0.085 | Carbonic anhydrase II inhibitor | 0.069 0.03 DBMET01437 0.085 0.023 DBMET00507 | DBMET00507 | |
| 0.035 | 0.136 | 0.068 | Nav1.8 sodium channel blocker | 0.068 0.059 DBMET01437 | DBMET01437 | |
| 0.052 | 0.154 | 0.217 | Protein kinase (CK2) alpha inhibitor | 0.217 0.021 DBMET01437 | DBMET01437 | |
| 0.082 | 0.184 | 0.417 | Protein-tyrosine phosphatase inhibitor | 0.145 0.084 DBMET00733 0.417 0.008 DBMET01437 0.149 0.079 DBMET00507 | DBMET01437 | |
| 0.006 | 0.109 | 0.015 | Thyroid hormone alpha antagonist | 0.015 0.012 DBMET00507 | DBMET00507 | |
| 0.06 | 0.162 | 0.086 | Potassium channel (Voltage-sensitive) activator | 0.086 0.077 DBMET02222 | DBMET02222 | |
| 0.155 | 0.259 | 0.483 | Sodium/bile acid cotransporter inhibitor | 0.313 0.068 DBMET00733 0.266 0.112 DBMET00540 0.328 0.055 DBMET01018 0.395 0.018 DBMET01437 0.483 0.005 DBMET00507 | DBMET00507 | |
| 0.091 | 0.196 | 0.315 | Platelet adhesion inhibitor | 0.134 0.125 DBMET00733 0.315 0.029 DBMET02222 0.161 0.094 DBMET01437 0.148 0.108 DBMET00507 | DBMET02222 | |
| 0.119 | 0.224 | 0.647 | Cardiotonic | 0.647 0.005 DBMET00540 0.57 0.009 DBMET01018 0.182 0.138 DBMET00507 | DBMET00540 | |
| 0.006 | 0.112 | 0.045 | Vitronectin receptor antagonist | 0.045 0.007 DBMET00507 | DBMET00507 | |
| 0.028 | 0.134 | 0.057 | CF transmembrane conductance regulator antagonist | 0.057 0.005 DBMET01437 | DBMET01437 | |
| 0.029 | 0.135 | 0.059 | Nitric oxide donor | 0.056 0.055 DBMET01437 0.059 0.051 DBMET00507 | DBMET00507 | |
| 0.051 | 0.159 | 0.087 | Estrogen receptor alpha antagonist | 0.077 0.053 DBMET00733 0.087 0.039 DBMET02222 0.08 0.049 DBMET01437 | DBMET02222 | |
| 0.132 | 0.239 | 0.296 | 12-Lipoxygenase inhibitor | 0.22 0.13 DBMET00733 0.262 0.102 DBMET02222 0.209 0.141 DBMET01018 0.296 0.082 DBMET01437 | DBMET01437 | |
| 0.057 | 0.165 | 0.099 | Bromodomain-containing protein 2 inhibitor | 0.099 0.042 DBMET01437 | DBMET01437 | |
| 0.01 | 0.12 | 0.081 | Glutamate (mGluR2) agonist | 0.081 0.008 DBMET01437 | DBMET01437 | |
| 0.018 | 0.128 | 0.038 | CDK5/p25 inhibitor | 0.038 0.032 DBMET02222 | DBMET02222 | |
| 0.019 | 0.131 | 0.103 | Carbonic anhydrase inhibitor | 0.089 0.031 DBMET01437 0.103 0.026 DBMET00507 | DBMET00507 | |
| 0.024 | 0.138 | 0.052 | CC chemokine 2 receptor antagonist | 0.052 0.042 DBMET01437 0.05 0.044 DBMET00507 | DBMET01437 | |
| 0.018 | 0.133 | 0.03 | Elastase 3A inhibitor | 0.03 0.021 DBMET01437 | DBMET01437 | |
| 0.018 | 0.133 | 0.03 | Elastase 2B inhibitor | 0.03 0.021 DBMET01437 | DBMET01437 | |
| 0.018 | 0.133 | 0.03 | Elastase 3B inhibitor | 0.03 0.021 DBMET01437 | DBMET01437 | |
| 0.104 | 0.219 | 0.327 | Free radical scavenger | 0.327 0.045 DBMET00733 0.317 0.047 DBMET02222 0.263 0.063 DBMET01018 0.274 0.059 DBMET01437 0.158 0.136 DBMET00507 | DBMET00733 | |
| 0.061 | 0.177 | 0.217 | Interleukin 1b antagonist | 0.217 0.016 DBMET02222 0.129 0.055 DBMET01437 | DBMET02222 | |
| 0.023 | 0.14 | 0.042 | Microtubule stabilization | 0.042 0.038 DBMET01437 | DBMET01437 | |
| 0.084 | 0.202 | 0.131 | Heat shock protein 90 antagonist | 0.131 0.096 DBMET00733 0.13 0.098 DBMET01437 | DBMET00733 | |
| 0.014 | 0.133 | 0.097 | Peroxisome proliferator-activated receptor alpha agonist | 0.097 0.013 DBMET01437 0.062 0.025 DBMET00507 | DBMET01437 | |
| 0.064 | 0.185 | 0.117 | Phosphodiesterase 6D inhibitor | 0.1 0.052 DBMET02222 0.117 0.028 DBMET01437 | DBMET01437 | |
| 0.012 | 0.133 | 0.041 | Liver X receptor beta agonist | 0.041 0.014 DBMET01437 | DBMET01437 | |
| 0.025 | 0.147 | 0.124 | Protein kinase C eta inhibitor | 0.068 0.029 DBMET00540 0.082 0.023 DBMET01018 0.124 0.011 DBMET01437 | DBMET01437 | |
| 0.021 | 0.144 | 0.059 | Protein 50S ribosomal subunit inhibitor | 0.059 0.032 DBMET00540 0.054 0.036 DBMET01018 | DBMET00540 | |
| 0.009 | 0.133 | 0.073 | Carbonic anhydrase XII inhibitor | 0.073 0.028 DBMET01437 | DBMET01437 | |
| 0.016 | 0.14 | 0.053 | Aromatase inhibitor | 0.053 0.046 DBMET02222 | DBMET02222 | |
| 0.082 | 0.21 | 0.413 | Sigma receptor agonist | 0.413 0.02 DBMET01437 | DBMET01437 | |
| 0.013 | 0.142 | 0.082 | Purinergic P2Y antagonist | 0.082 0.012 DBMET01437 0.042 0.034 DBMET00507 | DBMET01437 | |
| 0.009 | 0.139 | 0.044 | Peroxisome proliferator-activated receptor delta agonist | 0.044 0.015 DBMET01437 0.031 0.026 DBMET00507 | DBMET01437 | |
| 0.057 | 0.188 | 0.117 | MAP kinase kinase inhibitor | 0.117 0.076 DBMET01437 | DBMET01437 | |
| 0.091 | 0.224 | 0.254 | I kappa B kinase epsilon inhibitor | 0.254 0.036 DBMET01437 | DBMET01437 | |
| 0.012 | 0.145 | 0.046 | Estradiol 17 beta-dehydrogenase inhibitor | 0.046 0.027 DBMET01437 | DBMET01437 | |
| 0.003 | 0.138 | 0.088 | Egl nine homolog 3 inhibitor | 0.037 0.003 DBMET01437 0.088 0.002 DBMET00507 | DBMET00507 | |
| 0.008 | 0.146 | 0.071 | Carbonic anhydrase IX inhibitor | 0.071 0.032 DBMET01437 | DBMET01437 | |
| 0.004 | 0.143 | 0.023 | Endothelin B receptor antagonist | 0.023 0.011 DBMET01437 | DBMET01437 | |
| 0.016 | 0.156 | 0.188 | Xanthine dehydrogenase inhibitor | 0.188 0.005 DBMET01437 | DBMET01437 | |
| 0.009 | 0.15 | 0.114 | Urate transporter 1 inhibitor | 0.114 0.005 DBMET01437 | DBMET01437 | |
| 0.036 | 0.178 | 0.22 | Protein kinase (CK2) inhibitor | 0.22 0.015 DBMET01437 | DBMET01437 | |
| 0.004 | 0.148 | 0.027 | Angiotensin AT1A receptor antagonist | 0.027 0.008 DBMET01437 | DBMET01437 | |
| 0.01 | 0.156 | 0.262 | Nicotinic acid receptor 2 agonist | 0.262 0.003 DBMET01437 | DBMET01437 | |
| 0.026 | 0.171 | 0.064 | Amidase inhibitor | 0.063 0.059 DBMET02222 0.064 0.058 DBMET00507 | DBMET00507 | |
| 0.088 | 0.235 | 0.367 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.33 0.056 DBMET02222 0.367 0.046 DBMET01437 0.189 0.107 DBMET00507 | DBMET01437 | |
| 0.006 | 0.153 | 0.231 | Retinoid X beta receptor agonist | 0.231 0.002 DBMET01437 | DBMET01437 | |
| 0.039 | 0.187 | 0.055 | Lipocortins synthesis agonist | 0.055 0.05 DBMET01437 | DBMET01437 | |
| 0.016 | 0.166 | 0.137 | Dihydroorotate dehydrogenase inhibitor | 0.137 0.005 DBMET01437 | DBMET01437 | |
| 0.06 | 0.215 | 0.252 | Cytidine deaminase inhibitor | 0.165 0.065 DBMET02222 0.252 0.029 DBMET01437 | DBMET01437 | |
| 0.052 | 0.21 | 0.195 | AMP-activated protein kinase stimulant | 0.195 0.012 DBMET01437 0.123 0.046 DBMET00507 | DBMET01437 | |
| 0.064 | 0.222 | 0.205 | Interleukin 1 antagonist | 0.205 0.031 DBMET02222 0.112 0.101 DBMET01437 | DBMET02222 | |
| 0.03 | 0.191 | 0.124 | Androgen antagonist | 0.124 0.031 DBMET02222 0.086 0.059 DBMET01437 | DBMET02222 | |
| 0.108 | 0.268 | 0.298 | Lipoxygenase inhibitor | 0.192 0.149 DBMET00733 0.216 0.125 DBMET00540 0.223 0.119 DBMET02222 0.298 0.072 DBMET01018 0.276 0.084 DBMET01437 | DBMET01018 | |
| 0.006 | 0.167 | 0.149 | Retinoid X gamma receptor agonist | 0.149 0.002 DBMET01437 | DBMET01437 | |
| 0.007 | 0.169 | 0.017 | Factor IX inhibitor | 0.017 0.015 DBMET00540 | DBMET00540 | |
| 0.067 | 0.23 | 0.264 | Aryl hydrocarbon receptor agonist | 0.187 0.11 DBMET02222 0.264 0.073 DBMET01437 | DBMET01437 | |
| 0.045 | 0.211 | 0.403 | Chelator | 0.124 0.05 DBMET00733 0.2 0.024 DBMET01437 0.403 0.005 DBMET00507 | DBMET00507 | |
| 0.003 | 0.17 | 0.099 | Egl nine homolog 1 inhibitor | 0.037 0.004 DBMET01437 0.099 0.002 DBMET00507 | DBMET00507 | |
| 0.005 | 0.174 | 0.032 | Endothelin receptor antagonist | 0.032 0.016 DBMET01437 | DBMET01437 | |
| 0.042 | 0.211 | 0.114 | Glycogen synthase kinase-3 alpha inhibitor | 0.114 0.089 DBMET01437 | DBMET01437 | |
| 0.034 | 0.203 | 0.322 | Protein-tyrosine phosphatase 1B inhibitor | 0.322 0.009 DBMET01437 | DBMET01437 | |
| 0.046 | 0.216 | 0.104 | GABA receptor agonist | 0.104 0.073 DBMET01437 | DBMET01437 | |
| 0.095 | 0.264 | 0.298 | Antioxidant | 0.298 0.062 DBMET00733 0.249 0.084 DBMET02222 0.262 0.078 DBMET01018 0.264 0.077 DBMET01437 0.175 0.137 DBMET00507 | DBMET00733 | |
| 0.007 | 0.182 | 0.046 | Leukotriene B4 receptor 2 antagonist | 0.046 0.005 DBMET01437 | DBMET01437 | |
| 0.012 | 0.19 | 0.029 | Cyclophilin A inhibitor | 0.029 0.024 DBMET02222 | DBMET02222 | |
| 0.091 | 0.272 | 0.516 | Lipocortins synthesis antagonist | 0.516 0.003 DBMET02222 0.356 0.013 DBMET01437 0.15 0.105 DBMET00507 | DBMET02222 | |
| 0.008 | 0.191 | 0.098 | Farnesoid X receptor agonist | 0.098 0.004 DBMET01437 0.035 0.03 DBMET00507 | DBMET01437 | |
| 0.101 | 0.287 | 0.309 | Thyroid hormone antagonist | 0.19 0.171 DBMET01437 0.309 0.089 DBMET00507 | DBMET00507 | |
| 0.018 | 0.205 | 0.113 | Prostaglandin-E synthase inhibitor | 0.113 0.021 DBMET01437 0.072 0.047 DBMET00507 | DBMET01437 | |
| 0.005 | 0.193 | 0.019 | Endothelin A receptor antagonist | 0.019 0.017 DBMET01437 | DBMET01437 | |
| 0.048 | 0.239 | 0.183 | Lipid peroxidase inhibitor | 0.183 0.049 DBMET00733 0.133 0.081 DBMET01018 0.137 0.078 DBMET01437 | DBMET00733 | |
| 0.046 | 0.237 | 0.273 | M17 leucyl aminopeptidase inhibitor | 0.273 0.016 DBMET01437 | DBMET01437 | |
| 0.03 | 0.221 | 0.102 | DNA helicase inhibitor | 0.088 0.008 DBMET01437 0.102 0.005 DBMET00507 | DBMET00507 | |
| 0.107 | 0.306 | 0.409 | Hypoxia-inducible factor 1 alpha inhibitor | 0.338 0.049 DBMET00540 0.239 0.111 DBMET02222 0.409 0.028 DBMET01018 0.291 0.07 DBMET01437 0.283 0.074 DBMET00507 | DBMET01018 | |
| 0.044 | 0.245 | 0.15 | Beta glucuronidase inhibitor | 0.09 0.087 DBMET02222 0.15 0.025 DBMET01437 | DBMET01437 | |
| 0.131 | 0.334 | 0.241 | Caspase 3 stimulant | 0.229 0.132 DBMET00733 0.241 0.121 DBMET02222 | DBMET02222 | |
| 0.015 | 0.219 | 0.125 | Antineoplastic antibiotic | 0.125 0.037 DBMET02222 | DBMET02222 | |
| 0.118 | 0.323 | 0.324 | 15-Lipoxygenase inhibitor | 0.21 0.202 DBMET00733 0.302 0.131 DBMET02222 0.303 0.13 DBMET01018 0.324 0.115 DBMET01437 0.209 0.204 DBMET00507 | DBMET01437 | |
| 0.029 | 0.235 | 0.6 | Antiadrenergic | 0.6 0.005 DBMET00540 0.506 0.005 DBMET01018 | DBMET00540 | |
| 0.008 | 0.215 | 0.034 | Catechol O-methyltransferase inhibitor | 0.034 0.02 DBMET01018 | DBMET01018 | |
| 0.008 | 0.215 | 0.043 | DNA gyrase subunit B inhibitor | 0.043 0.019 DBMET01437 0.038 0.027 DBMET00507 | DBMET01437 | |
| 0.005 | 0.213 | 0.066 | Leukotriene B4 receptor 1 antagonist | 0.066 0.005 DBMET01437 | DBMET01437 | |
| 0.027 | 0.237 | 0.597 | Adrenaline antagonist | 0.597 0.005 DBMET00540 0.502 0.005 DBMET01018 | DBMET00540 | |
| 0.097 | 0.31 | 0.159 | CC chemokine 6 receptor antagonist | 0.159 0.013 DBMET01437 | DBMET01437 | |
| 0.055 | 0.268 | 0.113 | T cell inhibitor | 0.113 0.016 DBMET00507 | DBMET00507 | |
| 0.046 | 0.262 | 0.133 | Interleukin 5 antagonist | 0.113 0.029 DBMET00540 0.119 0.024 DBMET01018 0.133 0.016 DBMET01437 | DBMET01437 | |
| 0.012 | 0.228 | 0.09 | Stearoyl-CoA desaturase inhibitor | 0.09 0.009 DBMET00507 | DBMET00507 | |
| 0.042 | 0.264 | 0.118 | Thioredoxin inhibitor | 0.118 0.032 DBMET02222 0.087 0.067 DBMET01437 | DBMET02222 | |
| 0.033 | 0.26 | 0.059 | Bcl-xL inhibitor | 0.059 0.042 DBMET01437 | DBMET01437 | |
| 0.02 | 0.256 | 0.056 | DNA gyrase subunit A inhibitor | 0.056 0.013 DBMET01437 | DBMET01437 | |
| 0.052 | 0.292 | 0.087 | Interleukin 12 antagonist | 0.087 0.078 DBMET00733 | DBMET00733 | |
| 0.058 | 0.297 | 0.216 | Farnesoid X receptor antagonist | 0.137 0.07 DBMET00733 0.126 0.091 DBMET01018 0.216 0.018 DBMET01437 0.151 0.051 DBMET00507 | DBMET01437 | |
| 0.03 | 0.27 | 0.243 | Potassium channel large-conductance Ca-activated activator | 0.243 0.005 DBMET01437 0.073 0.041 DBMET00507 | DBMET01437 | |
| 0.007 | 0.251 | 0.053 | Retinoid X gamma receptor antagonist | 0.053 0.003 DBMET01437 | DBMET01437 | |
| 0.019 | 0.269 | 0.128 | CDC25B inhibitor | 0.075 0.033 DBMET00540 0.084 0.024 DBMET01018 0.128 0.009 DBMET01437 | DBMET01437 | |
| 0.053 | 0.305 | 0.194 | Interleukin 4 antagonist | 0.144 0.056 DBMET00733 0.131 0.071 DBMET00540 0.186 0.027 DBMET01018 0.194 0.024 DBMET01437 | DBMET01437 | |
| 0.007 | 0.261 | 0.147 | Alpha 1a adrenoreceptor agonist | 0.147 0.003 DBMET00540 0.096 0.003 DBMET01018 | DBMET00540 | |
| 0.061 | 0.319 | 0.158 | P-glycoprotein inhibitor | 0.158 0.105 DBMET01437 | DBMET01437 | |
| 0.035 | 0.294 | 0.075 | Heme oxygenase stimulant | 0.075 0.019 DBMET01437 | DBMET01437 | |
| 0.059 | 0.32 | 0.223 | Nitric oxide antagonist | 0.14 0.105 DBMET00733 0.223 0.06 DBMET02222 0.147 0.097 DBMET01018 0.149 0.096 DBMET01437 | DBMET02222 | |
| 0.077 | 0.347 | 0.29 | Thyroid hormone beta antagonist | 0.29 0.093 DBMET00507 | DBMET00507 | |
| 0.081 | 0.355 | 0.162 | MAP kinase kinase 4 inhibitor | 0.134 0.103 DBMET00733 0.162 0.043 DBMET01437 | DBMET01437 | |
| 0.015 | 0.299 | 0.074 | Myc inhibitor | 0.074 0.016 DBMET01437 | DBMET01437 | |
| 0.011 | 0.302 | 0.148 | Peroxisome proliferator-activated receptor gamma agonist | 0.148 0.013 DBMET01437 0.098 0.029 DBMET00507 | DBMET01437 | |
| 0.051 | 0.344 | 0.269 | Amyloid beta precursor protein antagonist | 0.269 0.026 DBMET01437 | DBMET01437 | |
| 0.015 | 0.314 | 0.144 | Leukotriene synthesis inhibitor | 0.144 0.01 DBMET02222 0.12 0.017 DBMET01437 | DBMET02222 | |
| 0.008 | 0.308 | 0.414 | Purinergic P2Y14 antagonist | 0.414 0.003 DBMET01437 | DBMET01437 | |
| 0.011 | 0.313 | 0.111 | Acetyl-CoA transferase inhibitor | 0.111 0.01 DBMET02222 | DBMET02222 | |
| 0.01 | 0.325 | 0.24 | Retinoic acid alpha receptor agonist | 0.24 0.002 DBMET01437 | DBMET01437 | |
| 0.04 | 0.355 | 0.22 | ABCA1 expression enhancer | 0.22 0.008 DBMET01437 | DBMET01437 | |
| 0.086 | 0.404 | 0.271 | Transcription factor inhibitor | 0.271 0.172 DBMET02222 0.234 0.199 DBMET01437 | DBMET02222 | |
| 0.028 | 0.346 | 0.171 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.171 0.01 DBMET01437 | DBMET01437 | |
| 0.012 | 0.332 | 0.043 | Protein kinase C beta I inhibitor | 0.043 0.006 DBMET01437 | DBMET01437 | |
| 0.007 | 0.328 | 0.065 | Peroxisome proliferator-activated receptor delta antagonist | 0.065 0.007 DBMET01437 0.035 0.019 DBMET00507 | DBMET01437 | |
| 0.019 | 0.34 | 0.138 | Prostaglandin F2 alpha antagonist | 0.138 0.005 DBMET01437 0.058 0.051 DBMET00507 | DBMET01437 | |
| 0.03 | 0.355 | 0.106 | Multidrug resistance-associated protein 1 inhibitor | 0.106 0.067 DBMET01437 0.093 0.092 DBMET00507 | DBMET01437 | |
| 0.006 | 0.331 | 0.255 | Retinoic acid beta receptor agonist | 0.255 0.002 DBMET01437 | DBMET01437 | |
| 0.018 | 0.361 | 0.147 | 5-Lipoxygenase inhibitor | 0.147 0.039 DBMET01437 | DBMET01437 | |
| 0.061 | 0.404 | 0.275 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.275 0.005 DBMET01437 | DBMET01437 | |
| 0 | 0.345 | 0.03 | Mannitol 2-dehydrogenase inhibitor | 0.03 0.001 DBMET01437 | DBMET01437 | |
| 0.084 | 0.434 | 0.259 | Toll-Like receptor agonist | 0.259 0.14 DBMET00540 0.225 0.174 DBMET01018 | DBMET00540 | |
| 0.035 | 0.394 | 0.468 | Electron transport complex I inhibitor | 0.126 0.04 DBMET00540 0.468 0.004 DBMET02222 0.123 0.043 DBMET01018 0.101 0.08 DBMET00507 | DBMET02222 | |
| 0.018 | 0.379 | 0.037 | Glucose-6-phosphate dehydrogenase inhibitor | 0.037 0.028 DBMET00507 | DBMET00507 | |
| 0.043 | 0.408 | 0.119 | CDK3/cyclin E inhibitor | 0.119 0.057 DBMET00507 | DBMET00507 | |
| 0.009 | 0.377 | 0.075 | NMDA 2B receptor antagonist | 0.075 0.023 DBMET01018 | DBMET01018 | |
| 0.005 | 0.374 | 0.046 | Prostaglandin D2 agonist | 0.032 0.02 DBMET00540 0.029 0.024 DBMET01018 0.046 0.009 DBMET01437 | DBMET01437 | |
| 0.007 | 0.377 | 0.029 | Liver X receptor alpha antagonist | 0.029 0.02 DBMET01437 | DBMET01437 | |
| 0.079 | 0.452 | 0.25 | Toll-Like receptor 7 agonist | 0.25 0.148 DBMET00540 0.219 0.179 DBMET01018 | DBMET00540 | |
| 0.004 | 0.378 | 0.047 | Leukotriene D4 antagonist | 0.047 0.01 DBMET01437 | DBMET01437 | |
| 0.003 | 0.378 | 0.038 | Estrogen receptor alpha agonist | 0.038 0.022 DBMET00733 0.035 0.023 DBMET01018 | DBMET00733 | |
| 0.003 | 0.386 | 0.123 | Retinoic acid alpha receptor antagonist | 0.123 0.002 DBMET01437 | DBMET01437 | |
| 0.068 | 0.459 | 0.259 | Growth factor agonist | 0.259 0.028 DBMET02222 0.157 0.127 DBMET00507 | DBMET02222 | |
| 0.005 | 0.396 | 0.207 | Retinoic acid receptor agonist | 0.207 0.003 DBMET01437 | DBMET01437 | |
| 0.01 | 0.404 | 0.036 | Estrogen-related receptor beta antagonist | 0.036 0.015 DBMET00733 0.033 0.022 DBMET01018 | DBMET00733 | |
| 0.006 | 0.4 | 0.105 | Retinoic acid gamma receptor agonist | 0.105 0.002 DBMET01437 | DBMET01437 | |
| 0.004 | 0.401 | 0.037 | Glycine transporter 1 inhibitor | 0.037 0.023 DBMET00507 | DBMET00507 | |
| 0.002 | 0.4 | 0.138 | Retinoic acid beta receptor antagonist | 0.138 0.002 DBMET01437 | DBMET01437 | |
| 0.012 | 0.418 | 0.071 | Lipase inhibitor | 0.071 0.053 DBMET01437 | DBMET01437 | |
| 0.014 | 0.42 | 0.107 | Carnitine palmitoyltransferase 1B inhibitor | 0.107 0.005 DBMET01437 0.049 0.031 DBMET00507 | DBMET01437 | |
| 0.036 | 0.444 | 0.244 | Prostaglandin dehydrogenase inhibitor | 0.244 0.13 DBMET01437 | DBMET01437 | |
| 0.003 | 0.411 | 0.125 | Retinoic acid receptor gamma antagonist | 0.125 0.002 DBMET01437 | DBMET01437 | |
| 0.051 | 0.462 | 0.33 | DNA directed DNA polymerase inhibitor | 0.33 0.148 DBMET02222 0.302 0.16 DBMET01437 0.248 0.193 DBMET00507 | DBMET02222 | |
| 0.044 | 0.468 | 0.303 | DNA polymerase beta inhibitor | 0.262 0.185 DBMET02222 0.303 0.164 DBMET01437 0.219 0.211 DBMET00507 | DBMET01437 | |
| 0.016 | 0.446 | 0.057 | Transcription factor AP-1 inhibitor | 0.057 0.051 DBMET01437 | DBMET01437 | |
| 0.003 | 0.437 | 0.03 | Estrogen receptor beta agonist | 0.03 0.023 DBMET00733 0.028 0.024 DBMET01018 | DBMET00733 | |
| 0.016 | 0.453 | 0.191 | M18 aspartyl aminopeptidase inhibitor | 0.099 0.093 DBMET00733 0.146 0.054 DBMET01018 0.191 0.036 DBMET01437 | DBMET01437 | |
| 0.004 | 0.444 | 0.055 | Estrogen agonist | 0.055 0.033 DBMET00733 0.047 0.037 DBMET01018 | DBMET00733 | |
| 0.038 | 0.48 | 0.283 | Alpha-glucosidase inhibitor | 0.283 0.169 DBMET01437 | DBMET01437 | |
| 0.029 | 0.476 | 0.09 | Thioredoxin reductase inhibitor | 0.09 0.041 DBMET01437 | DBMET01437 | |
| 0.01 | 0.459 | 0.105 | CDC25A inhibitor | 0.105 0.025 DBMET01437 | DBMET01437 | |
| 0.006 | 0.456 | 0.029 | Liver X receptor antagonist | 0.029 0.023 DBMET01437 | DBMET01437 | |
| 0.001 | 0.454 | 0.008 | Insulin like growth factor 3 antagonist | 0.008 0.003 DBMET01437 | DBMET01437 | |
| 0.014 | 0.478 | 0.068 | Topoisomerase II alpha inhibitor | 0.068 0.064 DBMET00507 | DBMET00507 | |
| 0.014 | 0.492 | 0.161 | Autotaxin inhibitor | 0.161 0.007 DBMET01437 | DBMET01437 | |
| 0.003 | 0.485 | 0.117 | Retinoic acid receptor antagonist | 0.117 0.002 DBMET01437 | DBMET01437 | |
| 0.005 | 0.489 | 0.039 | Protein kinase C beta II inhibitor | 0.039 0.012 DBMET01437 | DBMET01437 | |
| 0.029 | 0.513 | 0.17 | Platelet aggregation inhibitor | 0.17 0.107 DBMET00507 | DBMET00507 | |
| 0.004 | 0.497 | 0.048 | Carnitine palmitoyltransferase 1A inhibitor | 0.048 0.008 DBMET01437 | DBMET01437 | |
| 0.003 | 0.498 | 0.032 | Prostaglandin EP3 antagonist | 0.032 0.02 DBMET01437 | DBMET01437 | |
| 0.01 | 0.505 | 0.048 | Purinergic P2Y2 antagonist | 0.048 0.011 DBMET01437 | DBMET01437 | |
| 0.005 | 0.525 | 0.019 | Integrin beta6 antagonist | 0.019 0.004 DBMET00507 | DBMET00507 | |
| 0.005 | 0.526 | 0.019 | Guanylate cyclase 1 stimulant | 0.019 0.014 DBMET01437 | DBMET01437 | |
| 0.01 | 0.533 | 0.12 | Nicotinic acid receptor 1 agonist | 0.12 0.006 DBMET01437 | DBMET01437 | |
| 0.04 | 0.566 | 0.288 | NOS3 expression enhancer | 0.288 0.02 DBMET01437 | DBMET01437 | |
| 0.011 | 0.563 | 0.097 | Guanylate cyclase stimulant | 0.097 0.006 DBMET01437 | DBMET01437 | |
| 0.004 | 0.557 | 0.041 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.034 0.016 DBMET01437 0.041 0.012 DBMET00507 | DBMET00507 | |
| 0.003 | 0.556 | 0.011 | CD80 antagonist | 0.011 0.009 DBMET01437 | DBMET01437 | |
| 0.018 | 0.582 | 0.324 | Hypolipemic | 0.182 0.108 DBMET02222 0.324 0.042 DBMET01437 0.223 0.08 DBMET00507 | DBMET01437 | |
| 0.004 | 0.571 | 0.247 | Prostaglandin EP2 antagonist | 0.247 0.005 DBMET01437 0.092 0.021 DBMET00507 | DBMET01437 | |
| 0.005 | 0.58 | 0.191 | HIV-1 integrase (3'-Processing) inhibitor | 0.191 0.01 DBMET01437 | DBMET01437 | |
| 0.012 | 0.59 | 0.13 | Estrogen receptor beta antagonist | 0.13 0.023 DBMET00733 0.117 0.036 DBMET01018 | DBMET00733 | |
| 0.01 | 0.596 | 0.173 | Topoisomerase II inhibitor | 0.173 0.04 DBMET01437 | DBMET01437 | |
| 0.018 | 0.606 | 0.142 | Estrogen antagonist | 0.142 0.027 DBMET00733 0.128 0.042 DBMET01018 | DBMET00733 | |
| 0.01 | 0.602 | 0.377 | Mcl-1 antagonist | 0.377 0.013 DBMET01437 | DBMET01437 | |
| 0.01 | 0.607 | 0.136 | Cyclooxygenase 1 inhibitor | 0.136 0.066 DBMET01437 | DBMET01437 | |
| 0.006 | 0.606 | 0.205 | Plasminogen activator inhibitor antagonist | 0.205 0.004 DBMET01437 0.058 0.025 DBMET00507 | DBMET01437 | |
| 0.012 | 0.638 | 0.369 | Uric acid excretion stimulant | 0.369 0.004 DBMET01437 | DBMET01437 | |
| 0.005 | 0.639 | 0.18 | HIV-1 integrase (Strand Transfer) inhibitor | 0.065 0.039 DBMET02222 0.18 0.011 DBMET01437 | DBMET01437 | |
| 0.022 | 0.675 | 0.124 | MAP3K9 inhibitor | 0.124 0.106 DBMET01437 | DBMET01437 | |
| 0.002 | 0.66 | 0.188 | Prostaglandin EP1 antagonist | 0.188 0.004 DBMET01437 | DBMET01437 | |
| 0.002 | 0.673 | 0.053 | Egl nine homolog 2 inhibitor | 0.012 0.009 DBMET01437 0.053 0.004 DBMET00507 | DBMET00507 | |
| 0.004 | 0.679 | 0.109 | Aldose reductase inhibitor | 0.07 0.027 DBMET01437 0.109 0.016 DBMET00507 | DBMET00507 | |
| 0.036 | 0.74 | 0.406 | Antiinflammatory | 0.347 0.175 DBMET02222 0.406 0.136 DBMET01437 | DBMET01437 | |
| 0.004 | 0.721 | 0.566 | Protocollagen prolyl hydroxylase inhibitor | 0.049 0.005 DBMET01437 0.566 0.002 DBMET00507 | DBMET00507 | |
| 0.01 | 0.758 | 0.397 | Dual specificity phosphatase inhibitor | 0.397 0.015 DBMET01437 | DBMET01437 | |
| 0.007 | 0.756 | 0.028 | DNA topoisomerase IV inhibitor | 0.028 0.025 DBMET01437 | DBMET01437 | |
| 0.004 | 0.765 | 0.355 | Prostaglandin E2 antagonist | 0.355 0.004 DBMET01437 | DBMET01437 | |
| 0.01 | 0.781 | 0.249 | Streptokinase A inhibitor | 0.249 0.103 DBMET01437 | DBMET01437 | |
| 0.004 | 0.779 | 0.285 | Prostaglandin antagonist | 0.285 0.005 DBMET01437 0.057 0.034 DBMET00507 | DBMET01437 | |
| 0.005 | 0.78 | 0.122 | HIV-1 integrase inhibitor | 0.114 0.018 DBMET02222 0.122 0.014 DBMET01437 0.096 0.027 DBMET00507 | DBMET01437 | |
| 0.005 | 0.81 | 0.114 | DNA gyrase inhibitor | 0.114 0.014 DBMET01437 | DBMET01437 | |
| 0.007 | 0.815 | 0.389 | Dual specificity phosphatase 3 inhibitor | 0.389 0.015 DBMET01437 | DBMET01437 | |
| 0.007 | 0.815 | 0.2 | Thioredoxin glutathione reductase inhibitor | 0.2 0.172 DBMET01437 | DBMET01437 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |